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ABSTRACT OF THE DISSERTATION
Molecular Mechanisms of Axon Growth and Regeneration
by Dana Watt
Doctor of Philosophy in Biology and Biomedical Sciences
Neurosciences
Washington University in St. Louis, 2015
Associate Professor Valeria Cavalli, Chair
Neurons are cells with unique and extremely polarized morphologies. The axon allows
communication between the cell soma and the distantly located synaptic terminal and can extend up to

one meter in humans. This exceptional cellular structure therefore has specialized biological
processes dedicated to its growth, maintenance and regeneration. The structure that carries out
axon elongation during development and regeneration is the growth cone, which features a
cytoskeletal structure that is both highly dynamic yet consistent in overall organization. The
growth cone coordinates a leading edge of dynamic actin with the microtubules of the growing
axon, enabling directed outgrowth while maintaining the structural integrity of the axon. In the
axon, microtubules are oriented uniformly with their plus-ends facing away from the cell body,
providing directionality for cargo transport streams. Axonal transport is critical during growth
and after the axon has reached its target to ensure proper distribution of organelles and other
necessary components of the axonal biology machinery. Axon transport is especially important
because the axon is capable of independently carrying out tasks ranging from protein synthesis to
synaptic transmission. Therefore a thorough understanding of microtubule biology and axon
transport is critical for understanding how axons grow during development and regeneration.
I first investigated the role of a neuron-specific molecular motor adaptor, JIP3, in axon
elongation. JIP3 had been previously demonstrated to bind both the anterograde motor kinesin-1
viii

and the retrograde motor complex dynein/dynactin, generating cargo-specific directional
transport in the axon. Furthermore, our lab had also demonstrated that JIP3 was capable of
binding directly and activating dimeric kinesin heavy chain (KHC) for motility. While the
function of dimeric KHC is still debated, tetrameric kinesin-1 is known as the primary
anterograde motor in axons. I therefore investigated the role of JIP3 in regulating tetrameric
kinesin-1 motility, and the functional significance of this interaction in axons. I used a total
internal reflection fluorescence (TIRF)-based single molecule imaging assay to demonstrate that
JIP3 binds to the kinesin-1 tetramer in at least a 2:1 ratio. I also used this TIRF assay to show
that JIP3 binding to the cargo-adapting kinesin light chain (KLC) activated tetrameric kinesin-1
for microtubule binding, while JIP3 binding to KHC activated tetrameric kinesin-1 motility
along microtubules. Furthermore, while the JIP3/KLC interaction is dispensable for axon growth
and regeneration in neurons in vitro, the JIP3/KHC interaction is necessary for both these
activities. This work demonstrated that a single molecule can activate tetrameric kinesin-1 for
microtubule binding and motility. Furthermore, this work demonstrated that regulation of
molecular motor activity supports axon growth and regeneration.
I next investigated the small GTPase Ran and its role in axon elongation. Ran is best
known for its canonical function as a nuclear transport protein, but it can also stabilize
microtubules during mitotic spindle formation and is located in the axon. While Ran has a
proposed role in regulating a retrograde injury signaling complex in adult axons, it is unknown
whether Ran also regulates cytoskeletal dynamics in developing axons. I used Ran knockdown to
demonstrate that Ran promotes axon elongation on growth-promoting substrates, and restricts
axon elongation on growth-inhibiting substrates. This effect is at least partially mediated by
microtubule dynamics, as microtubule imaging using a cell-permeable pan-tubulin marker

ix

showed decreased microtubule dynamics in Ran knockdown cells on growth-promoting
substrates. Furthermore, I demonstrated that a Ran activating protein, RanBP10, is enriched in
growth cones and promotes axon elongation, and that both of these phenomena are Randependent. This work raises the exciting possibility that Ran controls microtubule dynamics in
the growth cone, distinct from its canonical role in nucleocytoplasmic trafficking.
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CHAPTER 1
Introduction: molecular mechanisms of axon growth and
regeneration

1

Introduction
Information in the brain is encoded and transmitted as an electrical signal by neurons,
brain cells specialized for long-range communication. For information to travel quickly across
long distances, neurons must be capable of rapidly transmitting information at up to 100 meters
per second. The neuron accomplishes this feat by extending a cellular process over distances as
great as one meter in the human body. This cellular process, called the axon, is a contiguous
extension of the cytoplasm. All mature neurons only have one axon, and electrical signaling via
the action potential occurs in only one direction: anterogradely, away from the cell soma and
towards the axon terminal. While the extreme polarity that the axon conveys on neural
morphology is necessary for neuronal function, development and maintenance of this
compartment is a challenge. During development, neurons must extend axons across great
distances to precise targets. After axon growth, the neuron needs to maintain the health of the
axon as it carries out the complex task of long-range signal transduction. Finally, if an axon
becomes injured, the neuron carries out a complex set of actions to attempt to regrow the axon
and reestablish neural architecture. These processes of axon growth, maintenance and
regeneration are accomplished via coordination of
(1) organellar structures which allow the axon to carry out complex cellular functions
independently of the cell body,
(2) a temporary structure dedicated to axon growth, the growth cone,
(3) transient transcription programs which are activated or suppressed in response to
extracellular signaling cues, and
(4) molecular motors which utilize the polarized microtubule structure of the axon to enable
long-term communication between the axon and soma.
2

The axon coordinates and executes complex cellular functions to support developmental
and regenerative growth
Axonal growth, maintenance and regeneration require complex cellular processes to
function successfully. Axons need to respond to signals from their postsynaptic partners,
environment and somas by transcribing or degrading proteins. And they must generate enough
energy to carry out these tasks locally. Accordingly, axons contain much of the machinery
localized to the cytoplasm of other cells, but specialized for use in the axon.
The large and relative somatic isolation of the axon makes the conclusion that the
axoplasm can carry out protein translation almost obvious; however for a long time the absence
of rough endoplasmic reticulum in the axon suggested that the axoplasm was incapable of
independent translation (1). Instead, researchers surmised that surrounding glia provided axons
with newly synthesized proteins, as they were better able to respond to local conditions than the
far-removed cell body (2). However, a growing body of evidence that ribosomes were located in
axons, mRNAs located to axons via specialized axon-directed untranslated regions, and that
isolated synapses could synthesize proteins strongly suggested that mature axons, and especially
the synapse, carry out protein translation (3–8). Further work on developing axons and growth
cones supported the conclusion that protein synthesis was an integral axonal function at all
stages. Now it is understood that even the growth cone contains the machinery necessary to
translate mRNAs into proteins (9). Importantly, not all axonal proteins are locally synthesized;
many are transported via axonal transport mechanisms described below. Why might an axon
locally translate proteins? One obvious advantage of local translation is its rapidity compared to
axon transport, which in some neurons could take days. The Jaffrey group, which has published
extensively on the topic of intra-axonal protein synthesis and mRNA translation, has argued that
3

axonal translation and protein degradation are linked (10). Proteins that need to undergo rapid
turnover in the growing axon, especially those involved in local signaling responses such as
growth cone collapse, would therefore be preferentially transcribed in axons. This hypothesis is
supported experimentally: during axon growth, local protein synthesis is necessary to specifically
enrich cytoskeletal components (11) and their regulators (12), signaling molecules (11, 13), and
translational machinery (14). During development, axon-synthesized signaling factors can also
contribute to retrograde signaling and subtype specification (15). Protein translation in the axon
might also be important for growth cone response to environmental cues, although this
conclusion is controversial (16–18). Asymmetrical translation of β-actin mRNA in response to
NGF, for example, has been proposed to mediate growth cone turning, discussed in more detail
below (19). Axonal protein synthesis is also necessary for axon regeneration (20, 21). In addition
to generating proteins necessary to form a new growth cone, newly-transcribed proteins act both
as retrograde injury signals (22–24) and to regulate retrograde injury signaling (25). Axonal
translational machinery therefore enables not only autonomous protein synthesis in the distal
axon, but also novel growth and injury signaling mechanisms.
In addition to carrying out protein translation, axons are also capable of degrading
proteins independently of the soma. Autophagy is an especially critical function in neurons,
which are postmitotic and therefore cannot rely on dilution and cell death to minimize the effects
of misfolded or nonfunctional proteins. Perhaps not surprisingly, mutations in the autophagocytic
pathway are often associated with neurodegenerative disease, underscoring the importance of
these proteins for axonal homeostasis (26). Developmentally, axonal autophagy seems to be
associated with a reduction in axon outgrowth (27). Autophagy is necessary for retrograde
signaling and growth cone collapse and turning in response to inhibitory factors (28–30).
4

However, autophagy is also associated positively with axon growth, as autophagosomal
machinery is upregulated in response to outgrowth-stimulating nerve growth factor (NGF) (31).
The autophagic machinery supports axon outgrowth by enabling membrane and membrane
receptor recycling within the growth cone (32–35). Additionally, maintenance of BiP-mediated
autophagy is necessary for axon outgrowth, defasciculation and pathfinding, underscoring the
importance of canonical protein quality control in axon outgrowth (36). The divergent effects of
axonal autophagy are partially explained by its interplay with other cellular functions. In close
cooperation with protein synthesis machinery, axonal autophagy machinery allows precision
tuning of growth cone dynamism in response to a range of attractive or repulsive cues (37). In
this model, the authors propose that local endocytosis enables rapid desensitization of the growth
cone to extracellular cues via internalization of cell surface receptors. Protein-synthesis
dependent resensitization of the growth cone then enables the axon to respond to increasing
concentrations of chemotactic cues. Different stages of the autophagic pathway therefore play
distinct roles in axon growth. Maintaining the machinery that enables localized translational
control through protein synthesis and degradation is an energy-intensive task, in addition to the
uniquely energy-intensive task of carrying out neurotransmission. The axon therefore also needs
to generate energy independently of the soma to survive.
Mitochondria have been recognized as an integral part of the axoplasmic niche for over
half a century (38). That axonal mitochondria have been implicated in neurodegenerative
diseases highlights their importance in axon biology: Alzheimer’s disease, Parkinson’s disease,
hereditary spastic paraplegia, multiple sclerosis, Huntington’s disease, and chemotherapyinduced neuropathic pain, to name a few, have all been linked to dysfunctional axonal
mitochondria (39–41). A critical factor of axonal mitochondrial biology is the proper positioning
5

of mitochondria to sites of high ATP consumption, including the synapse and the nodes of
Ranvier (6, 42). Mitochondrial localization along growing axons is particularly associated with
growth cones and branch sites, where intensive ATP-dependent actin polymerization, a primary
neuronal ATP sink, occurs (43). While growth cones are generally mitochondria-rich,
extracellular signals can also stimulate accumulation of mitochondria within the growth cone, as
is the case for NGF (44, 45). Mitochondrial enrichment by NGF is necessary for NGF-mediated
axon outgrowth, as local enrichment of mitochondria enables the formation of actin patches that
are precursors to filopodia (46). Similarly, mitochondrial capture along the length of developing
axons dictates placement of axonal branches, as an infusion of energy is necessary to remodel the
cytoskeleton and create a new growth cone (6, 42). Terminal axon branching is particularly
sensitive to mitochondrial transport, and mitochondrial capture at nascent presynapses is a
necessary prerequisite for this phenomenon in cortex in vivo (47). Mitochondrial localization can
also be affected by its fission/fusion dynamics, and a reduction in mitochondrial fusion decreases
axon elongation on permissive substrates by modulating growth cone lamellipodial dynamics
(48). Therefore mitochondria provide energy not only for homeostatic axonal functions, but also
for the actin polymerization-intensive task of axon outgrowth. While research on mitochondrial
function in injured axons focuses primarily on degeneration, it is likely that mitochondrial
function during developmental axon elongation and branching are conserved during
regeneration, as cytoskeletal remodeling is a common feature of both.
The axon contains all the molecular machinery necessary to function almost
independently from the cell body. Organellar structures present in the axon enable protein
regulation beginning at the mRNA level and local regulation of metabolites for energydependent processes. The complex cellular functions that the axon is capable of enable its
6

remarkable structure. They particularly support the subcellular structure responsible for carrying
out axon growth, the growth cone.

The growth cone is the structure that carries out axon
growth and regeneration
The growth cone is a temporary structure that
forms at the growing axon tip. In developing neurons,
nascent growth cones develop at the tips of multiple
neurites, and through the process of axon specification a
single neurite is selected as the axon, undergoing growthcone mediated elongation (49). In contrast, regenerating
axons form a new growth cone near the severed tip of the
injured, and already specified, axon (50). While the
process of growth cone formation is distinct during
development and regeneration, the biology of the formed growth cone is shared between the two.
The growth cone dynamically moves through its environment, extending the tip of the axon
while responding to extracellular growth cues. Growth cones thus rapidly change structure,
extending and retracting filopodia or lamellipodia in a matter of seconds. This dynamism
requires coordination of cytoskeletal dynamics and enables the axon to achieve growth rates of
up to 5 mm/day.
The growth cone has stereotyped cytoskeletal structure that maximizes its dynamics
while allowing maturation of the axon shaft (Figure 1) (51). Microtubule dynamics are greatly
influenced by myriad posttranslational modifications, although the purpose of each of these
7

modifications is not clear (52). However, microtubule acetylation and tyrosination are wellcharacterized in growth cone function. In the microtubule-rich axon shaft, microtubules are
heavily acetylated. Acetylation stabilizes microtubules, protecting the structural integrity of the
shaft so that it can perform the critical function of bidirectional microtubule-based axon
transport. In the dynamic body of the growth cone, cytoskeletal structures must rapidly
polymerize or depolymerize as the growth cone changes shape. Here, microtubules are primarily
tyrosinated, as tyrosination promotes disassembly, and therefore dynamism, of tubulin. The
highly dynamic outer fringe of the growth cone is enriched for actin, as actin-rich filopodia and
lamellipodia rapidly extend and retract. Coordination of these cytoskeletal elements is carried out
by a coterie of cytoskeletal organizing proteins.
Tubulin acetylation is carried out on the Lys40 residue by tubulin acetyltransferases
(TATs). The primary neuronal TAT is α-tubulin acetyltransferase 1 (αTAT1) (53). In C. elegans,
loss of αTAT1 (MEC-17) results in an altered distribution of critical axonal components,
including mitochondria (41). This results in spontaneous adult axonal degeneration, implying
that tubulin acetylation is critical for axon stability. Interestingly, while targeted knockout of
αTAT1 eliminates detectable tubulin acetylation in the mouse brain, it does not affect
development or overall viability, with the exception of male fertility (54). This suggests that
while tubulin acetylation may be critical for microtubule stability in lower eukaryotes, higher
eukaryotes may have developed redundant mechanisms for promoting microtubule stability in
the axon (i.e., via microtubule-associated proteins, the MAPs). A second TAT, Elp3, regulates
axon shape and synaptic number in Drosophila (55). Elp3 is a subunit of the Elongator complex,
which is primarily located in the nucleus where it stabilizes elongating RNA and displays histone
acetyltransferase activity (56, 57). Interestingly, Elp3 also displays tubulin acetylatransferase
8

activity and is located axonally in C. elegans (58, 59). Cytoplasmic Elp3 is critical for
acetylation of axonal tubulin in C. elegans, and this tubulin acetylation regulates velocity of
vesicular traffic in the axon. In Drosophila, Elp3 knockout results in an axon and synaptic
overgrowth and an overabundance of axonal branching, although whether these are the effects of
cytoplasmic or nuclear Elp3 is not clear. The microtubule stability achieved via tubulin
acetylation might be compensated for via other mechanisms, but seems to regulate some
components of axonal shape.
While the purpose of axonal tubulin acetylation is unclear, defects in tubulin
deacetylation have been linked to multiple neural degenerative disorders including Parkinson’s
disease and amyotrophic lateral sclerosis (60, 61). Tubulin deacetylation is carried out by the
class IIa histone deacetylases HDAC5 and HDAC6 and by Sirtuin2 (Sirt2) (62, 63). HDAC5 was
originally characterized as nuclear-located regulators of histone stability, however HDAC5 is
also located in the cytoplasm and axon, and HDAC6 is located exclusively in the cytoplasm.
HDAC6 is present in all neurons but is especially enriched in Purkinje cells, highly arborized
cells in the cerebellum (62). Axonal tubulin deacetylation by HDAC6 may therefore promote
axonal branching by enabling tubulin remodeling and formation of new growth cones along the
axon. While HDAC6 has been implicated as a tubulin deacetylase in developing, mature and
regenerating axons (64), HDAC5 has well-defined roles as an axonal tubulin deacetylase after
injury. After injury, HDAC5 is exported from the nucleus, increasing histone acetylation and
activating a set of regeneration-associated genes (65). HDAC5 is then transported anterogradely
into the axon, where it deacetylates tubulin specifically at the severed axon tip (63). This
combination of transcriptional changes and local tubulin modifications promotes axon
regeneration after injury. Sirt2 functions primarily in mature neurons to deacetylate tubulin,
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although Sirt2 also plays roles in oligodendroglial differentiation and morphology (60, 62, 66).
While the specific function of axonal Sirt2-based microtubule deacetylation remains unclear,
accumulation of axonal Sirt2 has been implicated in aging and dementia (66). While much work
has been done to illuminate the function of tubulin deacetylases in mature and regenerating
neurons, whether tubulin deacetylation plays a role in axon development remains unclear.
Tubulin tyrosination is carried out at the α-tubulin C-terminal by tubulin tyrosine ligase
(TTL) (67). Tyrosination of tubulin is generally associated with higher tubulin dynamic
instability and is therefore thought to be critical for maintaining the dynamism of the shape of the
growth cone (68). Loss of TTL and tubulin tyrosination results severe axon pathfinding defects
in vivo (67). In vitro, loss of TTL causes highly dystrophic growth cones and aberrations in small
GTPase signaling (69). A growing body of evidence suggests that tubulin tyrosination functions
as a signal for localization of microtubule plus-end binding proteins (+TIPs), which are critical
for regulating microtubule dynamics and initiating retrograde injury signaling. KIF3C, a
microtubule depolymerizing member of the kinesin superfamily, is rapidly upregulated after
injury and interacts specifically with EB3, a +TIP. This causes KIF3C to localize to growth
cones of regenerating axons, where it depolymerizes microtubules and contributes to their
dynamic instability. This localization of KIF3C is dependent on tubulin tyrosination. Work from
our lab confirmed that axon injury-induced tubulin tyrosination is necessary for +TIP recruitment
and retrograde injury signaling (70, 71). Tubulin tyrosination is therefore important for
regulating growth cone shape and axonal transport. Tubulin detyrosination is carried out by an
as-yet uncharacterized tubulin carboxypeptidase (TCP) (72). Since TCP has not yet been
identified, any importance of tubulin detyrosination remains elusive.
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How do tubulin dynamics direct axon outgrowth? As actin-rich filopodia explore the
neuronal environment, so-called “pioneer” microtubules invade the base of the filopodium,
providing the ground scaffolding for directional outgrowth (73–75). Dynamic, rapidlypolymerizing tyrosinated tubulin alone is capable of invading the rapidly growing filopodium.
This tyrosinated tubulin is also enriched for +TIPs, which are often downstream proteins in
canonical extracellular signaling cascades. The +TIP adenomatous polyposis coli (APC), for
example, is a downstream effector protein in the glycogen synthase kinase 3β (GSK3β)-signaling
cascade (76, 77). +TIPs can regulate microtubule stability via a number of mechanisms,
including stabilizing the tubulin/actin interface, bundling individual tubulin filaments, and acting
as a nucleation site for newly-synthesized cytoskeletal elements (73). Indeed, APC not only
bundles tubulin filaments, it also binds cytoskeletal mRNAs, and therefore acts as a nucleating
center for newly-trascribed cytoskeletal components and regulators (78, 79). As more tubulin
filaments invade the filopodium, the +TIPs accumulate, stabilizing microtubules in the direction
of axon outgrowth. While the elusive identity of TCP makes it impossible to say how
microtubules are detyrosinated, eventually the earlier pioneer microtubules mature into their
detyrosinated and eventually acetylated isoforms. Posttranslational modifications therefore
treadmill along axonal microtubules as the growth cone advances.
In addition to posttranslational modifications of microtubules, the growth cone also
consists of a variety of proteins that regulate the actin/microtubule interface. The
actin/microtubule junction is especially critical for filopodial dynamics, as pioneer microtubules
will invade actin-rich filopodia to lay the groundwork for axon outgrowth (73). The
spectraplakin family of proteins contain characteristic actin- and microtubule-binding domains
and are the primary proteins regulating actin/microtubule junctions (80). The spectraplakin
11

ACF7 (also known as MACF1, and with domain similarities to the Drosophila protein shortstop)
binds both microtubules and actin, providing a link between the actin-rich fringe and
microtubules (81). The microtubule/actin interface can also be modified indirectly. For example,
the +TIP Navigator interacts with the Rac guanine exchange factor TRIO in neurons. Since
Navigator is a +TIP, this allows selective enrichment of TRIO at growing microtubule ends in
the growth cone. As a Rac GEF, TRIO then locally enriches for Rac-GTP, which enables actin
remodeling and directed neurite outgrowth (82, 83). In addition to linking actin and tubulin
protrusion at the leading edge of the growth cone, actin/microtubule interactions are also critical
for tubulin bundling in the axon shaft. In the neck of the growth cone, the actin cytoskeleton is
organized as a series of lateral bands (84). This is in stark contrast to its filamentous (filopodial)
or meshwork (lamellipodial) organization at the leading edge of the growth cone, which is
typically in the direction of axon growth. This lateral actin organization enables MyosinIImediated contraction of the growth cone neck, as MyosinII movement along actin bands results
in a medial flux of actin. This actin contraction at the growth cone neck facilitates microtubule
bundling and therefore maturation of the microtubule cytoskeleton at the growth cone neck.
Therefore actin/microtubule dynamics promote directed outgrowth of the cytoskeleton along the
axis of axon growth and promote maturation of the cytoskeletal network at the stabilizing axon
shaft.
At the leading edge, the growth cone is at its most dynamic, rapidly cycling between
filopodial and lamellipodial morphologies carried out by its actin-rich fringe. The “treadmilling”
of actin polymerization to generate actin-rich structures and forward force has been wellcharacterized in multiple cell types (85, 86). In short, actin filaments rapidly polymerize in a
meshwork, wherein anterograde-facing barbed ends of filaments act as sites of profilin-mediated
12

actin polymerization, and retrograde-facing pointed ends of filaments act as sites of cofilinmediated actin depolymerization. Both profilin and cofilin are necessary for neuronal
development and are linked to neuronal disease. New actin filaments are nucleated off existing
actin filaments by the Arp2/3 complex, which is necessary for growth cone function. Filamin
promotes the gelating, or lateral crosslinking, of the actin meshwork in the body of the growth
cone and the lamellipodium, and was recently shown to be critical for axon regeneration (87).
Fascin bundles actin filaments, thereby promoting filopodial extrusion, and is also critical for
axon growth (88). Actin therefore comprises the majority of the leading edge of the growth cone,
and is the primary cytoskeletal force-generator at the cell membrane. Membrane-imbedded
extracellular signaling receptors are therefore often upstream regulators of actin dynamics.
The growth cone completes its task by carefully regulating cytoskeletal dynamics to
promote outgrowth while enabling maturation of the axon shaft. Highly dynamic filopodia and
lamellipodia advance the cell membrane and are achieved primarily through canonical actin
treadmilling. As actin advances the body of the growth cone forward, dynamic tyrosinated
tubulin invades actin-rich structures with the help of the actin/microtubule bridging +TIPs. +TIPs
facilitate bundling of the advancing tubulin filaments, which is facilitated in the neck of the
growth cone by MyosinII-mediated contraction of lateral actin bands. As microtubules bundle,
detyrosination and acetylation mark maturing tubulin as MAPs stabilize the tubulin bundles and
complete the process of axon maturation. This process is similar in development and
regeneration, although regenerating axons need to carry out the additional step of generating a
new growth cone from the mature axon shaft at the site of injury. This requires tubulin
deacetylation, tubulin tyrosination and the recruitment of +TIPs to severed microtubule tips, and
the reestablishment of cytoskeletal treadmilling (63, 70). Misregulation of the cytoskeletal
13

network during development or regeneration can lead to aberrant axon growth rates or
branching; additionally, misregulation of cytoskeletal remodeling after injury leads to the
formation of a retraction bulb and the failure of axon regeneration (89). Understanding growth
cone and axonal cytoskeletal regulation therefore contributes to our understanding of neural
development and repair.

Axon growth and regeneration are parallel processes dependent on intracellular and
extracellular signals
Axonal organellar and growth cone functions exist to carry out the needs of the neuron.
What does a neuron “need”? The most basic answer to this question is “to survive.” In order to
survive, the neuron activates whole-cell transcriptional programs in response to extracellular
cues. These transcriptional programs enable directed cell responses, such as axon elongation or
regeneration. Extracellular cues provide context and feedback for these responses, allowing a
neuron to maximize its function and survival.
Dedicated neuronal transcriptional programs promote axon growth and regeneration
Cell identity and certain cell activities are dictated by the availability of transcripts that
can be translated into proteins necessary for that identity or activity. The coterie of transcripts
available for translation in any cell is decided by transcriptional programs established by
transcription and epigenetic factors. Likewise, neurons are subject to several distinct
transcriptional programs depending on their developmental and environmental needs.
Transcriptomic analysis of neurons suggest distinct translational programs for axon development
(3, 90, 91) and injury (92–95), among other activities. Specificity of transcriptional programs is
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established via differential regulation of transcription factors (96–98), expression of specific
transcript isoforms (99, 100), and spatial regulation of transcripts (4, 101).
During development neurons have distinct needs. They must support axon outgrowth at a
rate of up to 5 mm/day. After a period of rapid axon outgrowth and the establishment of the
physical organization of circuitry, neurons must establish synapses and throughout its lifetime
regulate synaptic plasticity. Furthermore, neurons must carry out these complex tasks while the
axoplasm is physically remote from the soma. For this reason, axons are capable of carrying out
protein translation independently from the cell body (3, 102). The neuron establishes an axonspecific transcriptome by specifically trafficking mRNAs and translational machinery into the
axon via mRNA zip codes (3–5, 23). During development, the axonal transcriptome is enriched
for processes necessary for rapid outgrowth, especially mitochondrial components and
translational machinery (3). Within the axon, the translational machinery is specifically localized
to promote branch formation (6), growth cone function (9, 103) or synaptogenesis (21).
Furthermore, the developing axon may appropriate the translational machinery for a novel
purpose, as proposed by the Fainzilber group and explained in more detail below (104). In short,
timed anterograde trafficking of mRNA and the resultant timing of retrogradely transported
protein products of that mRNA would allow for somatic sensing of axonal length. Indeed, the
developing neuron not only has a unique transcriptome, but also may use the extreme lengths of
its axon to repurpose the transcriptional machinery to novel ends.
In addition to a specific developmental transcriptome, the neuron also possesses a
specialized regenerative transcriptome. This was discovered in part via the unique properties of
dorsal root ganglion (DRG) neurons, psuedobipolar neurons which extend one axon branch into
the periphery and another into the spinal cord. As was expected based on their extracellular
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environments, discussed in more detail below, peripheral branches of DRG neurons are wellknown to exhibit some regenerative capabilities, while central branches do not regenerate after
injury. However, a prior “conditioning” injury to the peripheral branch can enhance regeneration
of the central branch (105, 106). This conditioning injury is dependent on transcription, as
inhibition of mRNA synthesis abolishes the response (107). Differential regulation of so-called
regeneration-associated genes (RAGs) is therefore a cell-intrinsic prerequisite for axon
regeneration. While the injury-responsive transcriptome in DRGs shares some similarities with
the developmental neural transcriptome, including differential regulation of metabolic
machinery, it also displays unique characteristics, including upregulation of immunological
transcripts and differential regulation of the transcriptional machinery and especially
transcription factors (108–111). Furthermore, central nervous system (CNS) neurons, which are
typically incapable of significant axon regeneration, fail to activate the regeneration-associated
transcriptome, partially explaining their failure to regenerate (112, 113). Ectopic activation of
RAGs in CNS neurons can promote axon regeneration after injury, underscoring their functional
importance (112, 114, 115). The neuronal injury-induced transcriptome is therefore specialized
to the needs of a regenerating, rather than developing, axon, and is a prerequisite for successful
regeneration.
The extracellular neuronal environment directs axon growth and regeneration
While neurons maintain intracellular transcriptional programs, they ultimately need to
respond to extracellular cues guiding axon growth during development or regeneration. In the
growth cone, cell-surface receptors respond to both growth-promoting and growth repulsive
cues, which trigger long-term transcriptional effects via retrograde signaling or more immediate
effects on local cytoskeletal dynamics. Both attractive and repulsive chemotactic cues are
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necessary for directed axon growth during development and regeneration, as axons must grow
towards specific targets. However, the extracellular environment established during development
is often not optimized to support axon elongation.
One interesting means of efficiency is the axon’s integration of its translational regulation
machinery into its chemotactic response mechanisms. Growth-attractive and growth-repulsive
cues can stimulate translation of cytoskeletal proteins or their upstream regulators, with rapid
effects on growth cone shape. For example, the growth-attractive cues Netrin-1 and BDNF
promote translation of β-actin (116, 117) and asymmetric β-actin translation results in growth
cone turning towards these cues (19). Additionally, the microtubule-stabilizing protein β-catenin
is translated in response to the attractive cue neurotrophin-3, resulting in axon elongation (118).
Concomitantly, protein turnover via endocytosis is necessary for growth cone collapse in
response to repulsive cues (119). Spatially regulated protein translation can also mediate growth
cone collapse in response to repulsive cues, as in the case of the actin depolymerizer cofilin in
response to Slit2 (30), and the actin regulator RhoA (120) and the microtubule modulator
MAP1B in response to Semaphorin 3A (121, 122). Therefore the ability of the growth cone to
locally synthesize proteins is not only necessary due to the extreme remoteness of the growing
axon tip, but also to maximize cytoskeletal motility and responsiveness there.
In addition to changes of cytoskeletal dynamics in the immediate vicinity of the growth
cone, extracellular signaling can also have larger scale effects on neuronal biology, including
regulation of somatic responses. Often times, extracellular cues will activate proteins which act
both as immediate regulators of cytoskeletal dynamics at the growth cone, and as long-term
signaling cascades at the soma. GSK3, for example, is activated by extracellular Wnt via the
frizzled receptor in the axon (123–125). Activated GSK3 then locally regulates the activity of
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microtubule stabilizing proteins such as MAP1B and APC in the growth cone (126, 127).
Additionally, activated GSK3 is retrogradely transported to the soma, where it participates in
multiple axon growth- and regeneration-associated signaling pathways, including c-Jun, CREB,
β-catenin, p53, and SMAD signaling (122, 127, 128). These signaling pathways ultimately
regulate transcriptional programs, which dictate what transcripts are available in the axon.
Extracellular signaling can therefore have far-reaching effects on neuronal cell biology.
The extracellular signal caused by axon injury deserves special mention. This traumatic
response results in arguably the most significant cellular change a neuron will experience in its
mature life: the cell will activate the multitude cytoskeletal and transcriptional programs
discussed above, resulting in either axon regeneration or atrophy; cell survival or death.
Additionally, axon injury is the only time in a neuron’s lifetime when extracellular signaling is
activated by destruction of the diffusion barrier between the cytoplasm and the extracellular
matrix. Axotomy therefore causes the mixture of the intracellular and extracellular milieu at the
site of injury. This most immediately manifests in a loss of membrane polarization caused by an
influx of calcium (65, 129). This results in a back-propagating electrical signal which is rapidly
relayed to the cell body, activating early-stage injury signaling (65). Meanwhile, the axon locally
activates multiple signaling cascades at the site of injury which engage in reactivation of the
protein synthesis machinery and motor-dependent retrograde signaling (25, 130). Axons are
exceptionally poor at resealing membrane injuries, resulting in sustained ion influx and
membrane depolarization (131–133). The faster an axon can reseal its membrane, and reestablish
homeostatic intracellular and extracellular milieus, the more likely it is to regenerate. Otherwise,
sustained injury signaling results in the formation of a retraction bulb, mitophagy, and in many
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neurons, death. In the event of growth cone reformation, the axon must regenerate through its
extracellular environment, which may be permissive or inhibitory to axon growth.
The CNS, which consists of the brain and spinal cord, is highly inhibitory to axon
growth, while the peripheral nervous system (PNS, which classifies all non-CNS neurons) is
generally permissive for axon growth. This is partially attributable to the non-neuronal cells in
these distinct milieus. After injury the CNS inhibits axon regeneration by activating microglia
and astrocytes to form a glial scar (134–136). Rapidly proliferating glial cells physically inhibit
axon regeneration, and myelin debris and reactive astrocytes secrete growth-inhibitory signaling
molecules, including chondroitin sulfate proteoglycans (see chapter 3). In the PNS, however,
axon injury results in macrophage activation and efficient myelin debris clearance, and de- or
transdifferentiated Schwann cells secrete axon growth factors to promote directed functional
regeneration (reviewed in 135, 136). Extracellular signaling in the CNS can also block retrograde
injury responses and RAG activation. Importantly, the conditioning injury paradigm in DRG
neurons discussed above is nonreversible: an injury to the central branch will not prime the
peripheral branch for regeneration, suggesting a deficiency in retrograde injury signaling
specifically in the CNS (105). Therefore axon regeneration and growth are not only dependent
upon intrinsic neuronal growth capabilities, but also extracellular signals.
A recurring theme in axonal biology is the critical role of axon transport. Axon transport
positions axonal organelles where they are needed and delivers cargoes critical for axon growth
or synaptic transmission to the axon tip. Axon transport enables retrograde signaling to direct
transcriptional programs in response to extracellular growth or injury cues.
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Microtubule-based molecular motors are responsible for long-range axonal transport
Kinesin-1 and cytoplasmic dynein are the canonical MT-based molecular motors in axons
A defining feature of axons compared to unspecified neurons or dendrites is their highly
polarized microtubule structure. Microtubules have intrinsic directionality based on the structure
of the tubulin dimer (139). Microtubules are spiral oligomers made of individual dimers of αand β-tubulin. The tubulin dimers polymerize end-to-end, with the α and β subunits organizing
towards distinct ends of the tubulin oligomer. This directionality of microtubules is described by
“plus” and “minus” ends: α-tubulin lines up oriented towards the minus end, while β-tubulin
orients towards the plus end. In axons, the plus-ends of microtubules are uniformly oriented
away from the cell body, towards the distal axon. This microtubule orientation allows for
specific trafficking streams based on the directionality of molecular motor, since plus-end
directed motors will move anterogradely, while minus-end directed motors will move
retrogradely towards the cell body.
Rapid anterograde transport delivers vesicular cargoes to the axon tip, which during
growth contain the machinery for axon growth and after development are precursors for
neurotransmitter-containing vesicles. In contrast, slow axonal transport of certain cargoes, such
as organellar and cytoskeletal components, occurs up to fifty times slower than rapid axonal
transport (140, 141). Rapid retrograde transport allows for near real-time signaling of axonal
conditions: axon-to-soma signaling cascades are well-characterized in response to repulsive
signals, attractive signals, and axon injury (130, 142–146). Some cargoes, including
mitochondria, are bidirectional. These bidirectional cargoes might bind anterograde and
retrograde motors simultaneously and select a prevailing direction based on the number of
motors or on regulating specific motor activity, described (in the case of autophagosomes) in
20

more detail below. These distinct cargo streams suggest complex axonal “highways”: the
crowded microenvironment of the axoplasm must be coordinated enough to allow transport of
vesicular cargoes as fast as 400 mm/s.
Interestingly, the anterograde and retrograde molecular signaling streams themselves may
provide valuable information to neurons. Recently the Fainzilber group suggested a model of
axon length-sensing whereby timed release of anterograde cargoes and their subsequent
retrograde products generated an oscillating signal (103). Based on the frequency of this signal,
the neuron might sense how far it has grown and if it needs to continue on its growth trajectory
or begin the process of axonal maturation and synapse formation. The authors proposed an
mRNA-based signaling mechanism, where an axonally-directed mRNA is transported to the
axon terminal, where it is translated and its protein product is sent back to the soma via
retrograde transport. Since the frequency of this oscillating signal will decrease as axon length
increases, the cell can sense the length of the axon. This model is possible only if the activity of
molecular motors can be tightly regulated. Indeed, the axon has multiple layers of motor
regulation which enables both rapid transport and precise positioning of cargoes.
Molecular motor activity in the axon is tightly regulated via multiple mechanisms
A primary mechanism of motor regulation is autoinhibition: neither kinesin-1 nor
cytoplasmic dynein, common anterograde and retrograde axonal motors, are capable of anything
other than diffusive motility in the absence of binding partners. This mechanism is conserved
between different kinesin motors and cytoplasmic dynein because of its elegant simplicity: motor
trafficking uses ATP, and therefore intrinsic inhibition in the absence of binding partners
prevents fruitless energy expenditures (147). For kinesin, autoinhibition is conferred by both the
light and heavy chains. The tail of the heavy chain folds over and interacts directly with the
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motile head, inhibiting its interaction with microtubules (148). Additionally, KLC pushes apart
the two motile heads of the KHC dimer, preventing the release of ADP and the completion of the
ATP hydrolysis cycle (149). Therefore to initiate movement of kinesin-1 along microtubules,
regulatory proteins must bind both the KHC and KLC subunits (150, 151). Dynein is
autoinhibited via a slightly different mechanism than kinesin. When not bound by cargo, the two
motile dynein heads “stack” alongside one another; binding of the neck linker region pushes the
motile heads apart, enabling their directional movement along microtubules (152). Several
neuron-specific cargo adaptors exist which regulate both the autoinhibition and motility of
microtubule-based motors.
In addition to direct binding by cargo adapters and regulatory proteins, molecular motors
are also regulated by the number of motors attached to a single cargo. This is especially true for
large organellar structures, such as endosomes. The Holzbaur group has recently made a case
study of autophagosomal trafficking in axons (153–157). Autophagy is necessary for
mitochondrial turnover in axons: as mitochondria age or become damaged, they must be
efficiently cleared from the axon. In the distal axon, autophagosomes bind both kinesin-1 and
dynein and move in short bidirectional bursts, but do not sustain directed motility over long
periods. As the autophagosome matures, it undergoes a switch and begins directed retrograde
movement towards the cell body. As the autophagosome is transported back to the cell body, it
fuses with lysosomes and efficiently degrades mitochondria and other cargoes. This retrograde
transport of autophagosomes is necessary for their maturation and efficient degradation of
mitochondria. Interestingly, retrogradely transported autophagosomes are also bound to kinesin1. How is the directionality of the autophagosome, which binds both kinesin-1 and dynein,
regulated? Huntingtin acts in concert with HAP1 as a cargo adaptor, loading autophagosomes
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onto dynein. Additionally, JIP1 acts as a regulator of both dynein and kinesin-1 motors on the
autophagosome, but importantly, cannot bind both dynein and kinesin simultaneously. JIP1
binding to autophagosomes is mediated by the autophagosomal cargo adaptor LC3. While JIP1
ordinarily activates KHC for motility, interaction with LC3 abolishes this activation. JIP1 can
therefore act as a switch on autophagosome directionality, inhibiting KHC motility specifically
when LC3 is recruited to the autophagosome. Therefore sustained retrograde transport of
autophagosomes occurs only when efficient docking of autophagosomes to dynein by
Huntingtin/HAP1 and LC3-mediated JIP1 inhibition of KHC motility occur simultaneously. The
specific example of the autophagosome demonstrates the complexity of directional transport in
the axon, which often has multiple layers of regulatory control. Indeed, recent work has
suggested that vesicular cargoes might regulate the activity of their own motors by producing
ATP via glycolysis, adding the additional layer of metabolite regulation onto the already
complex transport machinery (158). An additional in-depth look at motor regulation by the JIP3
scaffolding protein is explored in Chapter 2. The complexity surrounding regulation of
microtubule-based motors in axons underscores their importance in axon growth.

Conclusions
The extreme polarity of the axon presents the neuron with unique biological challenges.
Developmentally, the neuron undergoes a dramatic morphological change, establishing shortand long-range connections which might extend across distances thousands of times the length of
its cell body. After a period of rapid growth, neurons need to keep these cytoplasmic
compartments alive for the lifetime of the organism, which might last more than a century. This
extreme morphology also leaves the axon uniquely susceptible to damage, and catastrophic axon
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injury is often met with attempts at regeneration. These feats are all the more impressive when
one considers that the neuron is postmitotic, and therefore accomplishes broad changes in
transcriptional programs, cellular biology and architectural remodeling within the lifetime of a
single cell. The work that follows are in-depth delves into two critical aspects of axonal biology:
molecular motor function and growth cone microtubule dynamics.

24

References
1.

S. Satkauskas, D. Bagnard, Local protein synthesis in axonal growth cones: what is next?
Cell Adh. Migr. 1, 179–84.

2.

R. J. Lasek, H. Gainer, J. L. Barker, Cell-to-cell transfer of glial proteins to the squid giant
axon. The glia-neuron protein trnasfer hypothesis. J. Cell Biol. 74, 501–23 (1977).

3.

L. F. Gumy et al., Transcriptome analysis of embryonic and adult sensory axons reveals
changes in mRNA repertoire localization. RNA. 17, 85–98 (2011).

4.

C. Gomes, T. T. Merianda, S. J. Lee, S. Yoo, J. L. Twiss, Molecular determinants of the
axonal mRNA transcriptome. Dev. Neurobiol. 74, 218–232 (2014).

5.

C. J. Donnelly et al., Limited availability of ZBP1 restricts axonal mRNA localization and
nerve regeneration capacity. Eur. Mol. Biol. Organ. J. 30, 4665–77 (2011).

6.

M. Spillane, A. Ketschek, T. T. Merianda, J. L. Twiss, G. Gallo, Mitochondria Coordinate
Sites of Axon Branching through Localized Intra-axonal Protein Synthesis. Cell Rep. 5,
1564–1575 (2013).

7.

J.-Q. Zheng et al., A Functional Role for Intra-Axonal Protein Synthesis during Axonal
Regeneration from Adult Sensory Neurons. J. Neurosci. 21, 9291–9303 (2001).

8.

Y. Kanai, N. Dohmae, N. Hirokawa, Kinesin transports RNA: isolation and
characterization of an RNA-transporting granule. Neuron. 43, 513–25 (2004).

9.

K. H. Zivraj et al., Subcellular profiling reveals distinct and developmentally regulated
repertoire of growth cone mRNAs. J. Neurosci. 30, 15464–78 (2010).

10.

A. Deglincerti et al., Coupled local translation and degradation regulate growth cone
collapse. Nat. Commun. 6, 6888 (2015).

11.

C. J. Donnelly et al., Axonally synthesized β-actin and GAP-43 proteins support distinct
modes of axonal growth. J. Neurosci. 33, 3311–22 (2013).

12.

M. Spillane et al., Nerve growth factor-induced formation of axonal filopodia and
collateral branches involves the intra-axonal synthesis of regulators of the actin-nucleating
25

Arp2/3 complex. J. Neurosci. 32, 17671–89 (2012).
13.

N. G. Gracias, N. J. Shirkey-Son, U. Hengst, Local translation of TC10 is required for
membrane expansion during axon outgrowth. Nat. Commun. 5, 3506 (2014).

14.

A. N. Kar, M. A. MacGibeny, N. M. Gervasi, A. E. Gioio, B. B. Kaplan, Intra-axonal
synthesis of eukaryotic translation initiation factors regulates local protein synthesis and
axon growth in rat sympathetic neurons. J. Neurosci. 33, 7165–74 (2013).

15.

S.-J. Ji, S. R. Jaffrey, Intra-axonal translation of SMAD1/5/8 mediates retrograde
regulation of trigeminal ganglia subtype specification. Neuron. 74, 95–107 (2012).

16.

B. a Walker, S.-J. Ji, S. R. Jaffrey, Intra-axonal translation of RhoA promotes axon growth
inhibition by CSPG. J. Neurosci. 32, 14442–7 (2012).

17.

S. Nedelec et al., Concentration-Dependent Requirement for Local Protein Synthesis in
Motor Neuron Subtype-Specific Response to Axon Guidance Cues. J. Neurosci. 32,
1496–1506 (2012).

18.

F. K. Roche, B. M. Marsick, P. C. Letourneau, Protein synthesis in distal axons is not
required for growth cone responses to guidance cues. J. Neurosci. 29, 638–52 (2009).

19.

K.-M. Leung et al., Asymmetrical beta-actin mRNA translation in growth cones mediates
attractive turning to netrin-1. Nat. Neurosci. 9, 1247–56 (2006).

20.

P. Verma et al., Axonal protein synthesis and degradation are necessary for efficient
growth cone regeneration. J. Neurosci. 25, 331–42 (2005).

21.

D. Yan, Z. Wu, A. D. Chisholm, Y. Jin, The DLK-1 Kinase Promotes mRNA Stability
and Local Translation in C. elegans Synapses and Axon Regeneration. Cell. 138, 1005–
1018 (2009).

22.

K. Ben-Yaakov et al., Axonal transcription factors signal retrogradely in lesioned
peripheral nerve. EMBO J. 31, 1350–63 (2012).

23.

R. B.-T. Perry et al., Subcellular knockout of importin β1 perturbs axonal retrograde
signaling. Neuron. 75, 294–305 (2012).
26

24.

L. J. Cox, U. Hengst, N. G. Gurskaya, K. A. Lukyanov, S. R. Jaffrey, Intra-axonal
translation and retrograde trafficking of CREB promotes neuronal survival. Nat. Cell Biol.
10, 149–59 (2008).

25.

D. Yudin et al., Localized regulation of axonal RanGTPase controls retrograde injury
signaling in peripheral nerve. Neuron. 59, 241–52 (2008).

26.

J. H. Son, J. H. Shim, K.-H. Kim, J.-Y. Ha, J. Y. Han, Neuronal autophagy and
neurodegenerative diseases. Exp. Mol. Med. 44, 89 (2012).

27.

B.-K. Ban et al., Autophagy negatively regulates early axon growth in cortical neurons.
Mol. Cell. Biol. 33, 3907–19 (2013).

28.

A. Joset, D. A. Dodd, S. Halegoua, M. E. Schwab, Pincher-generated Nogo-A endosomes
mediate growth cone collapse and retrograde signaling. J. Cell Biol. 188, 271–85 (2010).

29.

J. H. Hines, M. Abu-Rub, J. R. Henley, Asymmetric endocytosis and remodeling of beta1integrin adhesions during growth cone chemorepulsion by MAG. Nat. Neurosci. 13, 829–
37 (2010).

30.

M. Piper et al., Signaling mechanisms underlying Slit2-induced collapse of Xenopus
retinal growth cones. Neuron. 49, 215–228 (2006).

31.

J. P. Frampton, C. Guo, B. A. Pierchala, Expression of axonal protein degradation
machinery in sympathetic neurons is regulated by nerve growth factor. J. Neurosci. Res.
90, 1533–46 (2012).

32.

J. Falk, F. A. Konopacki, K. H. Zivraj, C. E. Holt, Rab5 and Rab4 regulate axon
elongation in the Xenopus visual system. J. Neurosci. 34, 373–91 (2014).

33.

O. Y. Ponomareva, I. C. Holmen, A. J. Sperry, K. W. Eliceiri, M. C. Halloran,
Calsyntenin-1 regulates axon branching and endosomal trafficking during sensory neuron
development in vivo. J. Neurosci. 34, 9235–48 (2014).

34.

T. Tojima, J. H. Hines, J. R. Henley, H. Kamiguchi, Second messengers and membrane
trafficking direct and organize growth cone steering. Nat. Rev. Neurosci. 12, 191–203
(2011).
27

35.

H. Kamiguchi, V. Lemmon, Recycling of the cell adhesion molecule L1 in axonal growth
cones. J. Neurosci. 20, 3676–86 (2000).

36.

C. B. Favero et al., Mutation of the BiP/GRP78 gene causes axon outgrowth and
fasciculation defects in the thalamocortical connections of the mammalian forebrain. J.
Comp. Neurol. 521, 677–96 (2013).

37.

M. Piper, S. Salih, C. Weinl, C. E. Holt, W. A. Harris, Endocytosis-dependent
desensitization and protein synthesis–dependent resensitization in retinal growth cone
adaptation. Nat. Neurosci. 8, 179–186 (2005).

38.

E. DE ROBERTIS, C. M. FRANCHI, The submicroscopic organization of axon material
isolated from myelin nerve fibers. J. Exp. Med. 98, 269–76 (1953).

39.

M. van Spronsen et al., TRAK/Milton motor-adaptor proteins steer mitochondrial
trafficking to axons and dendrites. Neuron. 77, 485–502 (2013).

40.

Q. Su, Q. Cai, C. Gerwin, C. L. Smith, Z.-H. Sheng, Syntabulin is a microtubuleassociated protein implicated in syntaxin transport in neurons. Nat. Cell Biol. 6, 941–53
(2004).

41.

B. Neumann, M. A. Hilliard, Loss of MEC-17 leads to microtubule instability and axonal
degeneration. Cell Rep. 6, 93–103 (2014).

42.

K. Tao, N. Matsuki, R. Koyama, AMP-activated protein kinase mediates activitydependent axon branching by recruiting mitochondria to axon. Dev. Neurobiol. 74, 557–
573 (2014).

43.

B. W. Bernstein, J. R. Bamburg, Actin-ATP hydrolysis is a major energy drain for
neurons. J. Neurosci. 23, 1–6 (2003).

44.

R. Morris, P. Hollenbeck, The regulation of bidirectional mitochondrial transport is
coordinated with axonal outgrowth. J. Cell Sci. 104, 917–927 (1993).

45.

S. R. Chada, P. J. Hollenbeck, Nerve growth factor signaling regulates motility and
docking of axonal mitochondria. Curr. Biol. 14, 1272–6 (2004).

46.

A. Ketschek, G. Gallo, Nerve growth factor induces axonal filopodia through localized
28

microdomains of phosphoinositide 3-kinase activity that drive the formation of
cytoskeletal precursors to filopodia. J. Neurosci. 30, 12185–97 (2010).
47.

J. Courchet et al., Terminal Axon Branching Is Regulated by the LKB1-NUAK1 Kinase
Pathway via Presynaptic Mitochondrial Capture. Cell. 153, 1510–1525 (2013).

48.

M. B. Steketee et al., Mitochondrial dynamics regulate growth cone motility, guidance,
and neurite growth rate in perinatal retinal ganglion cells in vitro. Invest. Ophthalmol. Vis.
Sci. 53, 7402–11 (2012).

49.

K. C. Flynn, The cytoskeleton and neurite initiation. Bioarchitecture. 3, 86–109 (2013).

50.

F. Bradke, J. W. Fawcett, M. E. Spira, Assembly of a new growth cone after axotomy: the
precursor to axon regeneration. Nat. Rev. Neurosci. 13, 183–193 (2012).

51.

E. W. Dent, F. B. Gertler, Cytoskeletal dynamics and transport in growth cone motility
and guidance. Neuron. 40 (2003), pp. 209–227.

52.

C. Janke, J. Chloë Bulinski, Post-translational regulation of the microtubule cytoskeleton:
mechanisms and functions. Nat. Rev. Mol. Cell Biol. 12, 773–786 (2011).

53.

N. Kalebic et al., αTAT1 is the major α-tubulin acetyltransferase in mice. Nat. Commun.
4, 1962 (2013).

54.

G.-W. Kim, L. Li, M. Gorbani, L. You, X.-J. Yang, Mice lacking α-tubulin
acetyltransferase 1 are viable but display α-tubulin acetylation deficiency and dentate
gyrus distortion. J. Biol. Chem. 288, 20334–50 (2013).

55.

N. Singh, M. T. Lorbeck, A. Zervos, J. Zimmerman, F. Elefant, The histone
acetyltransferase Elp3 plays in active role in the control of synaptic bouton expansion and
sleep in Drosophila. J. Neurochem. 115, 493–504 (2010).

56.

G. S. Winkler, A. Kristjuhan, H. Erdjument-Bromage, P. Tempst, J. Q. Svejstrup,
Elongator is a histone H3 and H4 acetyltransferase important for normal histone
acetylation levels in vivo. Proc. Natl. Acad. Sci. U. S. A. 99, 3517–22 (2002).

57.

T. G. Petrakis, B. Ø. Wittschieben, J. Q. Svejstrup, Molecular architecture, structurefunction relationship, and importance of the Elp3 subunit for the RNA binding of holo29

elongator. J. Biol. Chem. 279, 32087–92 (2004).
58.

J. A. Solinger et al., The Caenorhabditis elegans Elongator complex regulates neuronal
alpha-tubulin acetylation. PLoS Genet. 6, e1000820 (2010).

59.

C. Creppe et al., Elongator controls the migration and differentiation of cortical neurons
through acetylation of alpha-tubulin. Cell. 136, 551–64 (2009).

60.

V. P. Patel, C. T. Chu, Decreased SIRT2 activity leads to altered microtubule dynamics in
oxidatively-stressed neuronal cells: implications for Parkinson’s disease. Exp. Neurol.
257, 170–81 (2014).

61.

I. Taes et al., Hdac6 deletion delays disease progression in the SOD1G93A mouse model
of ALS. Hum. Mol. Genet. 22, 1783–90 (2013).

62.

C. M. Southwood, M. Peppi, S. Dryden, M. A. Tainsky, A. Gow, Microtubule
deacetylases, SirT2 and HDAC6, in the nervous system. Neurochem. Res. 32, 187–95
(2007).

63.

Y. Cho, V. Cavalli, HDAC5 is a novel injury-regulated tubulin deacetylase controlling
axon regeneration. Eur. Mol. Biol. Organ. J. 31, 3063–3078 (2012).

64.

M. a Rivieccio et al., HDAC6 is a target for protection and regeneration following injury
in the nervous system. Proc. Natl. Acad. Sci. U. S. A. 106, 19599–19604 (2009).

65.

Y. Cho, R. Sloutsky, K. M. Naegle, V. Cavalli, XInjury-Induced HDAC5 nuclear export is
essential for axon regeneration. Cell. 155 (2013), doi:10.1016/j.cell.2013.10.004.

66.

M. M. Maxwell et al., The Sirtuin 2 microtubule deacetylase is an abundant neuronal
protein that accumulates in the aging CNS. Hum. Mol. Genet. 20, 3986–96 (2011).

67.

C. Erck et al., A vital role of tubulin-tyrosine-ligase for neuronal organization. Proc. Natl.
Acad. Sci. U. S. A. 102, 7853–8 (2005).

68.

A. Ghosh-Roy, A. Goncharov, Y. Jin, A. D. Chisholm, Kinesin-13 and tubulin
posttranslational modifications regulate microtubule growth in axon regeneration. Dev.
Cell. 23, 716–28 (2012).
30

69.

S. Marcos et al., Tubulin tyrosination is required for the proper organization and
pathfinding of the growth cone. PLoS One. 4 (2009), doi:10.1371/journal.pone.0005405.

70.

W. Song, Y. Cho, D. Watt, V. Cavalli, Tubulin-tyrosine Ligase (TTL)-mediated Increase
in Tyrosinated α-Tubulin in Injured Axons Is Required for Retrograde Injury Signaling
and Axon Regeneration. J. Biol. Chem. 290, 14765–75 (2015).

71.

A. J. Moughamian, G. E. Osborn, J. E. Lazarus, S. Maday, E. L. F. Holzbaur, Ordered
recruitment of dynactin to the microtubule plus-end is required for efficient initiation of
retrograde axonal transport. J. Neurosci. 33, 13190–203 (2013).

72.

X. Fonrose et al., Parthenolide inhibits tubulin carboxypeptidase activity. Cancer Res. 67,
3371–8 (2007).

73.

E. A. Bearce, B. Erdogan, L. A. Lowery, TIPsy tour guides: how microtubule plus-end
tracking proteins (+TIPs) facilitate axon guidance. Front. Cell. Neurosci. 9, 241 (2015).

74.

A. Marx et al., Xenopus cytoplasmic linker-associated protein 1 (XCLASP1) promotes
axon elongation and advance of pioneer microtubules. Mol. Biol. Cell. 24, 1544–1558
(2013).

75.

A. I. M. Barth, H. Y. Caro-Gonzalez, W. J. Nelson, Role of adenomatous polyposis coli
(APC) and microtubules in directional cell migration and neuronal polarization. Semin.
Cell Dev. Biol. 19 (2008), pp. 245–251.

76.

V. Votin, W. J. Nelson, A. I. M. Barth, Neurite outgrowth involves adenomatous
polyposis coli protein and beta-catenin. J. Cell Sci. 118, 5699–708 (2005).

77.

D. Dikovskaya et al., Microtubule assembly by the Apc protein is regulated by importinbeta--RanGTP. J. Cell Sci. 123, 736–746 (2010).

78.

N. Preitner et al., APC Is an RNA-Binding Protein, and Its Interactome Provides a Link to
Neural Development and Microtubule Assembly. Cell. 158, 368–382 (2014).

79.

D. A. Applewhite et al., The spectraplakin Short stop is an actin-microtubule cross-linker
that contributes to organization of the microtubule network. Mol. Biol. Cell. 21, 1714–24
(2010).
31

80.

N. Sanchez-Soriano et al., Mouse ACF7 and drosophila short stop modulate filopodia
formation and microtubule organisation during neuronal growth. J. Cell Sci. 122, 2534–42
(2009).

81.

J. van Haren et al., Mammalian Navigators are microtubule plus-end tracking proteins that
can reorganize the cytoskeleton to induce neurite-like extensions. Cell Motil.
Cytoskeleton. 66, 824–38 (2009).

82.

J. van Haren et al., Dynamic microtubules catalyze formation of navigator-TRIO
complexes to regulate neurite extension. Curr. Biol. 24, 1778–85 (2014).

83.

D. T. Burnette et al., Myosin II activity facilitates microtubule bundling in the neuronal
growth cone neck. Dev. Cell. 15, 163–9 (2008).

84.

E. M. Craig, D. Van Goor, P. Forscher, A. Mogilner, Membrane tension, myosin force,
and actin turnover maintain actin treadmill in the nerve growth cone. Biophys. J. 102,
1503–13 (2012).

85.

H. CHEN, B. BERNSTEIN, J. BAMBURG, Regulating actin-filament dynamics. Trends
Biochem. Sci. 25, 19–23 (2000).

86.

Y. Cho, D. Park, V. Cavalli, Filamin A Is Required in Injured Axons for HDAC5 Activity
and Axon Regeneration. J. Biol. Chem. 290, 22759–70 (2015).

87.

J. Zanet et al., Fascin promotes filopodia formation independent of its role in actin
bundling. J. Cell Biol. 197, 477–86 (2012).

88.

A. Ertürk, F. Hellal, J. Enes, F. Bradke, Disorganized microtubules underlie the formation
of retraction bulbs and the failure of axonal regeneration. J. Neurosci. 27, 9169–9180
(2007).

89.

W. Xu et al., Adolescent mouse takes on an active transcriptomic expression during
postnatal cerebral development. Genomics. Proteomics Bioinformatics. 12, 111–9 (2014).

90.

A. Jaerve, F. Kruse, K. Malik, H.-P. Hartung, H. W. Müller, Age-dependent modulation
of cortical transcriptomes in spinal cord injury and repair. PLoS One. 7, e49812 (2012).

91.

Q. Mei et al., Hierarchically clustering to 1,033 genes differentially expressed in mouse
32

superior colliculus in the courses of optic nerve development and injury. Cell Biochem.
Biophys. 67, 753–61 (2013).
92.

S. Li et al., An age-related sprouting transcriptome provides molecular control of axonal
sprouting after stroke. Nat. Neurosci. 13, 1496–1504 (2010).

93.

B. Barrette, E. Calvo, N. Vallières, S. Lacroix, Transcriptional profiling of the injured
sciatic nerve of mice carrying the Wld(S) mutant gene: Identification of genes involved in
neuroprotection, neuroinflammation, and nerve regeneration. Brain. Behav. Immun. 24,
1254–1267 (2010).

94.

S. Li et al., The transcriptional landscape of dorsal root ganglia after sciatic nerve
transection. Sci. Rep. 5, 16888.

95.

M. A. Gates, R. Kannan, E. Giniger, A genome-wide analysis reveals that the Drosophila
transcription factor Lola promotes axon growth in part by suppressing expression of the
actin nucleation factor Spire. Neural Dev. 6, 37 (2011).

96.

E. F. Andersen, N. S. Asuri, M. C. Halloran, In vivo imaging of cell behaviors and F-actin
reveals LIM-HD transcription factor regulation of peripheral versus central sensory axon
development. Neural Dev. 6, 27 (2011).

97.

S. J. Ji, S. R. Jaffrey, Axonal transcription factors: Novel regulators of growth cone-tonucleus signaling. Dev. Neurobiol. 74, 245–258 (2014).

98.

J. K. Lerch et al., Isoform diversity and regulation in peripheral and central neurons
revealed through RNA-Seq. PLoS One. 7, e30417 (2012).

99.

J. K. Lerch, J. L. Bixby, V. P. Lemmon, Isoform diversity and its importance for axon
regeneration. Neuropathology. 32, 420–431 (2012).

100. A. M. Taylor et al., Axonal mRNA in Uninjured and Regenerating Cortical Mammalian
Axons. J. Neurosci. 29, 4697–4707 (2009).
101. E. Koenig, a Giuditta, Protein-synthesizing machinery in the axon compartment.
Neuroscience. 89, 5–15 (1999).
102. L. Davis, P. Dou, M. DeWit, S. B. Kater, Protein synthesis within neuronal growth cones.
33

J. Neurosci. 12, 4867–4877 (1992).
103. I. Rishal et al., A motor-driven mechanism for cell-length sensing. Cell Rep. 1, 608–16
(2012).
104. P. M. Richardson, V. M. Issa, Peripheral injury enhances central regeneration of primary
sensory neurones. Nature. 309, 791–793 (1984).
105. P. N. Hoffman, A conditioning lesion induces changes in gene expression and axonal
transport that enhance regeneration by increasing the intrinsic growth state of axons. Exp.
Neurol. 223, 11–8 (2010).
106. D. S. Smith, J. H. Skene, A transcription-dependent switch controls competence of adult
neurons for distinct modes of axon growth. J. Neurosci. 17, 646–658 (1997).
107. M. Costigan et al., Replicate high-density rat genome oligonucleotide microarrays reveal
hundreds of regulated genes in the dorsal root ganglion after peripheral nerve injury. BMC
Neurosci. 3, 16 (2002).
108. V. S. Mashanov, O. R. Zueva, J. E. García-Arrarás, Transcriptomic changes during
regeneration of the central nervous system in an echinoderm. BMC Genomics. 15, 357
(2014).
109. D. L. Moore, J. L. Goldberg, Multiple transcription factor families regulate axon growth
and regeneration. Dev. Neurobiol. 71, 1186–1211 (2011).
110. M. L. Szpara et al., Analysis of gene expression during neurite outgrowth and
regeneration. BMC Neurosci. 8, 100 (2007).
111. R. P. Smith et al., Transcriptional profiling of intrinsic PNS factors in the postnatal
mouse. Mol. Cell. Neurosci. 46, 32–44 (2011).
112. A. B. Schmitt et al., Identification of regeneration-associated genes after central and
peripheral nerve injury in the adult rat. BMC Neurosci. 4, 8 (2003).
113. M. J. Finelli, J. K. Wong, H. Zou, Epigenetic regulation of sensory axon regeneration after
spinal cord injury. J. Neurosci. 33, 19664–76 (2013).
34

114. W. J. Buchser et al., Peripheral nervous system genes expressed in central neurons induce
growth on inhibitory substrates . PLoS One. 7, e38101 (2012).
115. Y. Sasaki et al., Phosphorylation of zipcode binding protein 1 is required for brain-derived
neurotrophic factor signaling of local beta-actin synthesis and growth cone turning. J.
Neurosci. 30, 9349–58 (2010).
116. J. Yao, Y. Sasaki, Z. Wen, G. J. Bassell, J. Q. Zheng, An essential role for beta-actin
mRNA localization and translation in Ca2+-dependent growth cone guidance. Nat.
Neurosci. 9, 1265–73 (2006).
117. M. Kundel, K. J. Jones, C. Y. Shin, D. G. Wells, Cytoplasmic polyadenylation elementbinding protein regulates neurotrophin-3-dependent beta-catenin mRNA translation in
developing hippocampal neurons. J. Neurosci. 29, 13630–13639 (2009).
118. D. S. Campbell, C. E. Holt, Chemotropic responses of retinal growth cones mediated by
rapid local protein synthesis and degradation. Neuron. 32, 1013–1026 (2001).
119. K. Y. Wu et al., Local translation of RhoA regulates growth cone collapse. Nature. 436,
1020–1024 (2005).
120. C. Li, G. J. Bassell, Y. Sasaki, Fragile X Mental Retardation Protein is Involved in Protein
Synthesis-Dependent Collapse of Growth Cones Induced by Semaphorin-3A. Front.
Neural Circuits. 3, 11 (2009).
121. Y. Q. Zhang et al., Drosophila fragile x-related gene regulates the MAP1B homolog
Futsch to control synaptic structure and function. Cell. 107, 591–603 (2001).
122. W.-Y. Kim, W. D. Snider, Functions of GSK-3 Signaling in Development of the Nervous
System. Front. Mol. Neurosci. 4, 44 (2011).
123. A. J. Valvezan, F. Zhang, J. A. Diehl, P. S. Klein, Adenomatous polyposis coli (APC)
regulates multiple signaling pathways by enhancing glycogen synthase kinase-3 (GSK-3)
activity. J. Biol. Chem. 287, 3823–32 (2012).
124. Z. L. Hua, S. Jeon, M. J. Caterina, J. Nathans, Frizzled3 is required for the development of
multiple axon tracts in the mouse central nervous system. Proc. Natl. Acad. Sci. U. S. A.,
1–10 (2014).
35

125. S. A. Purro et al., Wnt regulates axon behavior through changes in microtubule growth
directionality: a new role for adenomatous polyposis coli. J. Neurosci. 28, 8644–8654
(2008).
126. R. Meli, P. Weisová, F. Propst, Repulsive axon guidance by Draxin is mediated by protein
Kinase B (Akt), glycogen synthase kinase-3β (GSK-3β) and microtubule-associated
protein 1B. PLoS One. 10, e0119524 (2015).
127. Saijilafu et al., PI3K-GSK3 signalling regulates mammalian axon regeneration by
inducing the expression of Smad1. Nat. Commun. 4, 2690 (2013).
128. P. M. Bilimoria et al., A JIP3-regulated GSK3β/DCX signaling pathway restricts axon
branching. J. Neurosci. 30, 16766–16776 (2010).
129. G. Mandolesi, F. Madeddu, Y. Bozzi, L. Maffei, G. M. Ratto, Acute physiological
response of mammalian central neurons to axotomy: ionic regulation and electrical
activity. FASEB J. 18, 1934–1936 (2004).
130. V. Cavalli, P. Kujala, J. Klumperman, L. S. B. Goldstein, Sunday Driver links axonal
transport to damage signaling. J. Cell Biol. 168, 775–787 (2005).
131. A. Nehrt, K. Hamann, H. Ouyang, R. Shi, Polyethylene glycol enhances axolemmal
resealing following transection in cultured cells and in ex vivo spinal cord. J.
Neurotrauma. 27, 151–61 (2010).
132. R. Shi, X. Qiao, N. Emerson, A. Malcom, Dimethylsulfoxide enhances CNS neuronal
plasma membrane resealing after injury in low temperature or low calcium. J. Neurocytol.
30, 829–39.
133. X. Y. Xie, J. N. Barrett, Membrane resealing in cultured rat septal neurons after neurite
transection: evidence for enhancement by Ca(2+)-triggered protease activity and
cytoskeletal disassembly. J. Neurosci. 11, 3257–67 (1991).
134. I. B. Wanner et al., Glial scar borders are formed by newly proliferated, elongated
astrocytes that interact to corral inflammatory and fibrotic cells via STAT3-dependent
mechanisms after spinal cord injury. J. Neurosci. 33, 12870–86 (2013).
36

135. Y.-M. Yuan, C. He, The glial scar in spinal cord injury and repair. Neurosci. Bull. 29,
421–35 (2013).
136. D. A. Morgenstern, R. A. Asher, J. W. Fawcett, Chondroitin sulphate proteoglycans in the
CNS injury response. Prog. Brain Res. 137, 313–332 (2002).
137. M. Dezawa, Central and peripheral nerve regeneration by transplantation of Schwann cells
and transdifferentiated bone marrow stromal cells. Anat. Sci. Int. 77, 12–25 (2002).
138. H. A. Kim, T. Mindos, D. B. Parkinson, Plastic fantastic: Schwann cells and repair of the
peripheral nervous system. Stem Cells Transl. Med. 2, 553–7 (2013).
139. E. W. Dent, S. L. Gupton, F. B. Gertler, The growth cone cytoskeleton in Axon outgrowth
and guidance. Cold Spring Harb. Perspect. Biol. 3, 1–39 (2011).
140. A. D. Pilling, D. Horiuchi, C. M. Lively, W. M. Saxton, Kinesin-1 and Dynein are the
primary motors for fast transport of mitochondria in Drosophila motor axons. Mol. Biol.
Cell. 17, 2057–68 (2006).
141. K. E. Miller, M. P. Sheetz, Direct evidence for coherent low velocity axonal transport of
mitochondria. J. Cell Biol. 173, 373–81 (2006).
142. P. D. Chowdary, D. L. Che, B. Cui, Neurotrophin Signaling via Long-Distance Axonal
Transport. Annu. Rev. Phys. Chem. 63 (2012), pp. 571–594.
143. K. Dolma et al., Presenilin influences glycogen synthase kinase-3 β (GSK-3β) for kinesin1 and dynein function during axonal transport. Hum. Mol. Genet. 23, 1121–33 (2014).
144. R. Eva et al., ARF6 directs axon transport and traffic of integrins and regulates axon
growth in adult DRG neurons. J. Neurosci. 32, 10352–64 (2012).
145. R. Eva, J. Fawcett, Integrin signalling and traffic during axon growth and regeneration.
Curr. Opin. Neurobiol. 27C, 179–185 (2014).
146. A. Suzuki et al., The scaffold protein JIP3 functions as a downstream effector of the small
GTPase ARF6 to regulate neurite morphogenesis of cortical neurons. FEBS Lett. 584,
2801–2806 (2010).
37

147. K. J. Verhey, J. W. Hammond, Traffic control: regulation of kinesin motors. Nat. Rev.
Mol. Cell Biol. 10, 765–777 (2009).
148. D. Cai, A. D. Hoppe, J. A. Swanson, K. J. Verhey, Kinesin-1 structural organization and
conformational changes revealed by FRET stoichiometry in live cells. J. Cell Biol. 176,
51–63 (2007).
149. H. Y. K. Kaan, D. D. Hackney, F. Kozielski, The structure of the kinesin-1 motor-tail
complex reveals the mechanism of autoinhibition. Science. 333, 883–5 (2011).
150. T. L. Blasius, D. Cai, G. T. Jih, C. P. Toret, K. J. Verhey, Two binding partners cooperate
to activate the molecular motor Kinesin-1. J. Cell Biol. 176, 11–7 (2007).
151. D. Watt, R. Dixit, V. Cavalli, JIP3 Activates Kinesin-1 Motility to Promote Axon
Elongation. J. Biol. Chem. 290, 15512–25 (2015).
152. T. Torisawa et al., Autoinhibition and cooperative activation mechanisms of cytoplasmic
dynein. Nat. Cell Biol. 16, 1118–24 (2014).
153. M.-M. Fu, J. J. Nirschl, E. L. F. Holzbaur, LC3 Binding to the Scaffolding Protein JIP1
Regulates Processive Dynein-Driven Transport of Autophagosomes. Dev. Cell. 29, 577–
90 (2014).
154. J. P. Caviston, A. L. Zajac, M. Tokito, E. L. F. Holzbaur, Huntingtin coordinates the
dynein-mediated dynamic positioning of endosomes and lysosomes. Mol. Biol. Cell. 22,
478–492 (2011).
155. Y. C. Wong, E. L. F. Holzbaur, The regulation of autophagosome dynamics by huntingtin
and HAP1 is disrupted by expression of mutant huntingtin, leading to defective cargo
degradation. J. Neurosci. 34, 1293–305 (2014).
156. M. Fu, E. L. F. Holzbaur, MAPK8IP1/JIP1 regulates the trafficking of autophagosomes in
neurons. Autophagy. 10, 2079–81 (2014).
157. J. P. Caviston, J. L. Ross, S. M. Antony, M. Tokito, E. L. F. Holzbaur, Huntingtin
facilitates dynein/dynactin-mediated vesicle transport. Proc. Natl. Acad. Sci. U. S. A. 104,
10045–50 (2007).
38

158. D. Zala et al., Vesicular glycolysis provides on-board energy for fast axonal transport.
Cell. 152, 479–491 (2013).

39

CHAPTER 2
JIP3 activates kinesin-1 motility to promote axon elongation

This chapter contains a manuscript previously published:
Watt D, Dixit R and Cavalli V. (2015). JIP3 activates kinesin-1 motility to promote axon
elongation. J Biol Chem 290(25): 15512-25.
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Abstract
Kinesin-1 is a molecular motor responsible for cargo transport along microtubules and
plays critical roles in polarized cells such as neurons. Kinesin-1 can function as a dimer of two
heavy chains (KHC), which harbor the motor domain, or as a tetramer in combination with two
accessory light chains (KLC). To ensure proper cargo distribution, kinesin-1 activity is precisely
regulated. Both KLC and KHC subunits bind cargoes or regulatory proteins to engage the motor
for movement along microtubules. We previously showed that the scaffolding protein JIP3
interacts directly with KHC in addition to its interaction with KLC and positively regulates
dimeric KHC motility. Here we report that JIP3 activates tetrameric kinesin-1 motility. Using an
in vitro motility assay, we show that JIP3 binding to KLC engages kinesin-1 with microtubules,
and that JIP3 binding to KHC promotes kinesin-1 motility along microtubules. We tested the in
vivo relevance of these findings using axon elongation as a model for kinesin-1-dependent
cellular function. We demonstrate that JIP3 binding to KHC, but not KLC, is essential for axon
elongation in hippocampal neurons as well as axon regeneration in sensory neurons. These
findings reveal that JIP3 regulation of kinesin-1 motility is critical for axon elongation and
regeneration.
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Introduction
The kinesin-1 molecular motor is essential for cellular function, transporting cargoes
along microtubules to distinct locales with precision timing. Kinesin-1 conventionally refers to a
heterotetramer consisting of two kinesin heavy chains (KHC), which harbor the motor domain,
and two non-motile light chains (KLC) (1–3). However, kinesin-1 can also function as a dimer of
two motile KHC (4–13). Although KHC contains the force–generating component and provides
motility for the kinesin-1 molecule, KHC also inhibits its own motility in the absence of cargo or
regulatory proteins (14–17). The KHC tail can bind to the motor head domain and microtubules,
creating a paused state for kinesin-1 (14). The KLC subunits act both as a cargo adapter for KHC
and inhibit microtubule binding and motility of KHC in the absence of cargo (18, 19). Since the
kinesin-1 tetramer is dually autoinhibited in the absence of binding partners, regulatory proteins
must bind both the KHC and KLC to relieve inhibition and promote binding and movement
along microtubules (20).
Neurons depend on kinesin-1 to transport cargoes along the extreme length of axons for
efficient long-distance intracellular communication. Kinesin-1 plays critical roles during axon
specification (21–23), growth (24), maintenance (25–27), organelle positioning (28), and
regeneration (29–31). Defects in kinesin-1 cargo delivery or motility lead to neurological
disorders (32–40), underscoring the importance of regulating kinesin-1 motility for neuronal
function. However, the cellular mechanisms that control kinesin-1 motile properties remain
poorly understood.
We previously showed that the c-Jun terminal kinase (JNK)-interacting protein 3, JIP3
(also known as JSAP1 or Sunday Driver) interacts with both KHC and KLC and promotes
motility of dimeric KHC in vitro (5), suggesting that JIP3 regulates kinesin-1 motility in axons.
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In agreement with this notion, previous studies have shown that JIP3 mutation leads to axonal
transport defects in C. elegans (41–43) and D. melanogaster (44). Both JIP3 null mice and
neuronal specific conditional JIP3 knockout mice are perinatal lethal and display severe axon
guidance defects of the telencephalic commissure (45–47). At the cellular level, absence of JIP3
in cerebellar granule neurons reduces axon length but increases axon branching (48). In cortical
neurons, JIP3 absence stimulates neurite elongation and branching (49). Although the
localization of JIP3 to axon tips by kinesin-1 correlates with axon elongation in hippocampal
neurons (50), whether modulation of kinesin-1 motile properties by JIP3 contributes to axon
elongation remains unknown. We therefore sought to directly determine whether JIP3 regulates
tetrameric kinesin-1 in vitro, and how JIP3 interaction with kinesin-1 subunits regulates axon
elongation.
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Results
JIP3 differentially regulates kinesin-1 for microtubule binding and motility
By virtue of its non-overlapping KLC and KHC binding domains, JIP3 has the potential
to activate tetrameric kinesin-1 for microtubule binding and motility (5, 20). To test this
possibility, we used a total internal reflection fluorescence microscopy (TIRF) based in vitro
motility assay, as previously described (5, 20, 51) (Figure 1A). COS-7 cells were used to express
wild-type JIP3 or JIP3 lacking the KHC or KLC binding site (5), as well as KLC-mCit and Flag–
KHC (Figure 1B,C). Cell lysates were mixed before the motility assay and an excess of FLAGJIP3 (WT or deletion mutants) was used (Figure 1D). Since KLC has no intrinsic motile activity,
mCit-positive puncta moving along rhodamine-labeled microtubules represent KLC-KHC
complexes (i.e., tetrameric kinesin-1) (20).
When mixed with control lysates lacking JIP3, KLC-mCit rarely displayed motile events
(Supplemental video S1), in agreement with previous findings (20). This was expected since
KLC inhibits the microtubule binding and motility of KHC (19, 20, 52). Under control
conditions, the binding frequency of KLC-mCit is 0.11 ± 0.01 events/µm and the motile
efficiency is 0.22 ± 0.04 events/10µm of microtubule (Figure 1F-G). The presence of WT JIP3
lysate doubled both the binding frequency (0.22 ± 0.02 events/µm) and motile efficiency (0.50 ±
0.07 events/10µm) of KLC-mCit (Figure 1F-G and Supplemental video S2), indicating that WT
JIP3 activates kinesin-1 for microtubule binding and motility. JIP3ΔKLC lysates were unable to
significantly increase the binding frequency of KLC-mCit (0.15 ± 0.02 events/µm) compared to
control lysates, but they increased the motile efficiency of KLC-mCit close to the levels obtained
using WT JIP3 lysates (0.42 ± 0.08 events/10µm) (Figure 1F-G and Supplemental video S3). In
contrast, JIP3ΔKHC lysates resulted in a high binding frequency that is similar to WT JIP3
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lysates (0.21 ± 0.02 events/µm), but only modestly increased the motile efficiency compared to
control lysates (0.34 ± 0.05 events/10µm)( Figure 1F-G and Supplemental video S4). Together,
these data suggest that JIP3 interaction with KLC promotes binding of kinesin-1 to microtubules,
and that JIP3 interaction with KHC binding promotes motility of kinesin-1 along microtubules.
To explore further how JIP3 regulates kinesin-1 motility, we measured the velocity and
run length of motile events (Figure 1H-I, and supplemental figure S5). Rare motile events
observed in the presence of control lysates moved at an average velocity of 0.17 ± 0.01 µm/sec
and an average run length of 0.44 ± 0.02 µm. In the presence of WT JIP3, we observed a
significant increase in the velocity (0.21 ± 0.01 µm/sec) and run length (0.64 ± 0.03 µm) of
motile events compared to control lysates. The velocity of KLC-mCit puncta were comparable to
those reported using a similar in vitro assay (20), but were lower than those we measured
previously for dimeric KHC motility (5). To determine if the lower velocities were due to the
presence of KLC or due to slight differences in experimental conditions, we measured dimeric
KHC velocity by imaging GFP-JIP3 puncta in the presence of Flag-KHC, as described (5). We
observed that dimeric KHC moved at 0.25± 0.02 µm/sec in the presence of WT JIP3
(Supplemental figure S5A-C). The overall low velocity we measured thus likely reflects slight
differences in experimental conditions. Nonetheless, we observed statistically significant
differences in kinesin-1 velocity and run length in the presence of the different JIP3 constructs.
JIP3ΔKLC lysate increased the velocity of KLC-mCit puncta similar to WT JIP3 lysate, while
JIP3ΔKHC lysate did not (Figure 1H). These data indicate that JIP3 binding to KHC, but not
KLC, contributes to regulation of kinesin-1 velocity. Run lengths of KLC-mCit puncta were
highest in the presence of WT JIP3 lysate and were modestly lower in the presence of both
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JIP3ΔKHC and JIP3ΔKLC lysates (Figure 1I), indicating that the binding of JIP3 to both KHC
and KLC regulates the off-rate of kinesin-1.
Given the important role of JIP3 binding to KHC for kinesin-1 motility, we next sought
to determine the stoichiometry of JIP3 and KHC complexes in vitro. To this end, we
immobilized dimeric KHC and its associated WT GFP-JIP3 molecules on rhodamine-labeled
microtubules by using AMPPNP and conducted single-molecule photobleaching assays as
described previously (53). In these assays, the most frequent number of photobleaching steps
was 4, indicating 4 JIP3 molecules per KHC dimer (Figure 1J). We also measured up to 8
photobleaching steps, which may result from two unresolved KHC dimers bound to a
microtubule and photobleaching of all or some of the associated GFP-JIP3 molecules. We rarely
measured photobleaching steps less than 4. Based on this analysis, we conclude that at least four
JIP3 molecules bind per KHC dimer, and therefore the stoichiometry for JIP3:KHC is likely to
be at least 2:1.
JIP3 is required for axon elongation
To test whether modulation of kinesin-1 motile properties by JIP3 contributes to axon
elongation, we first evaluated axon morphology of cultured hippocampal neurons isolated from
JIP3 knockout (KO) (45) or littermate control E18 embryos (Figure 2A,B). After 5 days in
culture, neurons were fixed and stained for tau, an axonal marker, and MAP2, which is enriched
in dendrites (Figure 2C). Given the possible function of JIP3 at the axon initial segment (43), and
the role of the JIP1 in axon specification (54), we first determined whether absence of JIP3
affects axon specification by measuring the number of tau-positive axons. No effect on axon
number was detected between the groups, indicating that JIP3 is dispensable for axon
specification (Figure 2D). We next measured the length and branching of both axons and
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dendrites. Absence of JIP3 significantly reduced axon length (379 ± 18 µm WT versus 322 ± 15
µm KO) (Figure 2E), in agreement with what was reported in cerebellar granule neurons (48).
JIP3 heterozygous neurons also showed a reduction in axon length compared to WT (332 ± 13
µm). We observed no effect on axon branching (ANOVA p=0.23, Figure 2F), in contrast to what
has been reported in cerebellar granule and cortical neurons (48, 49). Importantly, neither length
nor branching of MAP2-positive dendrites were affected by the absence of JIP3 (ANOVA
p=0.81 and 0.86, respectively, Figure 2G-H), indicating that JIP3 contributes specifically to axon
elongation in mouse hippocampal neurons.
JIP3 binding to KHC is required to promote axon elongation
To determine whether binding of JIP3 to KHC and KLC differentially affects axon
elongation, we performed rescue experiments with our JIP3 deletion mutants. EGFP-tagged WT
JIP3, JIP3ΔKLC, JIP3ΔKHC and JIP3ΔΔ (Figure 1B) were expressed in hippocampal neurons
isolated from JIP3 KO E18 embryos. At DIV5, neurons were fixed and stained for tau and
MAP2 to assess axon morphology (Figure 3A and Supplemental figure S6). We note that
electroporated JIP3 KO neurons consistently grew more robustly than non-electroporated
neurons (compare figure 2C and 3A). Only neurons with EGFP signal evident in the axon were
selected for analysis. Both JIP3ΔKLC and JIP3ΔKHC localized to the axon and were enriched at
the axon tip, similar to WT JIP3, while JIP3ΔΔ primarily localized to the cell body and initial
portion of the axon (Figure 3A), as previously reported (5, 50). Compared to the EGFP vector
control, neurons expressing WT JIP3 and JIP3ΔKLC extended longer axons, indicating that both
constructs rescued the axon elongation defects (441 ± 40 µm, 577 ± 53 µm and 636 ± 62 µm
respectively, Figure 3A-B). In contrast, expression of JIP3ΔKHC or JIP3ΔΔ failed to rescue
axon length defects (498 ± 44 µm and 505 ± 54 µm, respectively). We observed no significant
47

effect on axon branching (ANOVA p=0.35, Figure 3C) or on the length and branching of MAP2positive dendrites (ANOVA p=0.25 and 0.33 respectively, Figure 3D, E). These results suggest
that JIP3 binding to KHC, but not KLC, is sufficient to promote axon elongation.
Deletion of the KHC binding domain in JIP3 has a dominant-negative effect
Because JIP3 can homo-oligomerize (5, 55) we next determined if JIP3 lacking the KHC
binding domain had dominant-negative effects on axon morphology in a WT background. For
these experiments, we used rat hippocampal neurons and assessed axon and dendrite morphology
at DIV5 with tau/MAP2 staining as above (Supplemental figure S7). Only neurons with EGFP
signal present in the axon were analyzed. As observed in mice hippocampal neurons, both
JIP3ΔKLC and JIP3ΔKHC localized to the axon and were enriched at the axon tip, while
JIP3ΔΔ primarily localized in a punctate pattern in the cell body and initial portion of the axon
(Figure 4A). Whereas expression of WT JIP3 and JIP3ΔKLC had no effect on axon length when
compared with vector controls (655 ± 39 µm, 626 ± 38 µm and 562 ± 36 µm, respectively,
Figure 4A-B), expression of JIP3ΔKHC or JIP3ΔΔ essentially halved the total axon length
compared to vector controls (347 ± 25 µm and 326 ± 24 µm respectively). These results suggest
that JIP3ΔKHC and JIP3ΔΔ act as dominant-negative mutants. The dominant-negative effect of
JIP3ΔΔ on axon growth has been reported previously (50) and attributed to its inability to
localize to axon tips. However, we observed that JIP3ΔKHC, which localized to the axon tip,
also reduced axon elongation (Figure 4A,B). The dominant-negative effect therefore seems
attributable to lack of JIP3 interaction with KHC and not solely due to the mislocalization of
JIP3. In this rat hippocampal assay, JIP3ΔKHC and JIP3ΔΔ reduced axon branching compared
to vector controls (6.8 ± 0.4, 6.5 ± 0.5 and 9.8 ± 0.4 branches respectively, Figure 4C),
suggesting that JIP3 can regulate axon branching in certain cases, as reported previously (48,
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49). Importantly, dendrite length was not different between any of the groups (ANOVA p=0.42),
and dendrite branching, while reduced by the expression of JIP3ΔKHC and JIP3ΔΔ compared to
controls (4.9 ± 0.2, 4.6 ± 0.2 and 5.7 ± 0.3 branches respectively), was affected to a much
smaller degree than axon branching (Figure 4D-E). These data provide further evidence for the
importance of JIP3 binding to KHC, but not KLC, for axon elongation and, in some cell types,
branching.
JIP3 interaction with KHC is required for axon regeneration
To test if JIP3-dependent regulation of kinesin-1 contributes to axon growth following
injury, we used axon regeneration assays. Axon growth after injury is distinct from axon growth
during development, but both processes depend on kinesin-1 driven transport (29–31). We used
embryonic dorsal root ganglion (DRG) neurons to test for axon regeneration. This neuronal type
extends only axons (56) and can be cultured in a “spot”, which leads to large numbers of radially
growing axons that are amenable to measuring growth and regeneration (57). To establish a
baseline for the effects of JIP3 mutants in this neuronal subtype, we used a lentiviral system to
infect DRGs with EGFP-tagged wild type and mutant JIP3 on DIV1 and then assayed their
growth on DIV3. Wild type JIP3 and JIP3 deletion mutants were expressed at a similar level
(Figure 5A). However, none of the JIP3 mutants had an effect on axon outgrowth during normal
development of DRG neurons (Figure 5B, C), in contrast to our hippocampal neuron results
(Figures2-4). This finding indicates that JIP3 function likely differs in different neuronal
subtypes.
Nevertheless, we tested the effect of JIP3/kinesin-1 interactions on axon regeneration,
using an assay we developed previously (57). Embryonic DRG neurons were plated in a spot
culture and infected with lentiviral EGFP-tagged WT or mutant JIP3 at DIV3. At DIV7, axons
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were injured mechanically and 12h later cultures were fixed and stained with the regenerating
axon marker SCG10 (58). Axon regeneration was assessed by measuring the regeneration index,
normalizing SCG10 intensity distal to the site of injury to SCG10 intensity proximal to the site of
injury. A regeneration index of 0 would indicate a complete lack of regeneration. Vector treated
embryonic DRGs produced a regeneration index of 36 ± 4%, indicating that these neurons
produce robust axon regeneration in response to injury (Figure 5D, E). WT JIP3 and JIP3ΔKLC
produced modestly but not significantly lower regeneration indices of 28 ± 3% and 28 ± 3%,
respectively, compared to vector controls. Expression of either JIP3ΔKHC or JIP3ΔΔ
significantly reduced the regeneration index compared to vector transfected controls (21 ± 2%
and 22 ± 3%, respectively). Importantly, the reduction in the regeneration index was not due to
mislocalization of the regeneration marker SCG10 (Supplemental figure S8).
Since JIP3 also plays a role in retrograde injury signaling and activation of the proregenerative program (58, 59), we tested whether JIP3ΔKHC and JIP3ΔΔ reduce axon
regeneration by decreasing the phosphorylation of c-Jun, a regeneration-associated protein (60).
DRG neurons were cultured and infected as described above and immunostained for
phosphorylated c-Jun (p-c-Jun) (Figure 5F). Compared to uninjured controls, injury elicited a
robust p-c-Jun staining in all cases. These results indicate that the reduced axon regeneration
observed in the presence of JIP3ΔKHC or JIP3ΔΔ does not result from defects in retrograde
signaling after injury, and likely involves other activities that rely on the JIP3-KHC interaction.
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Discussion
Here, we show that JIP3 activates tetrameric kinesin-1 in two different ways depending
on whether it binds to KLC or KHC. Specifically, JIP3’s interaction with KLC promotes binding
of kinesin-1 to microtubules, whereas JIP3’s interaction with KHC promotes motility of kinesin1 along microtubules. While this dual action of JIP3 might be important for maximally activating
kinesin-1 motility, our in vivo experiments show that JIP3 binding to KHC, but not KLC, is
sufficient to rescue axon elongation defects caused by the loss of JIP3 in cultured neurons. In
addition, expression of a JIP3 mutant lacking the KHC binding domain reduces axon elongation
and axon regeneration. Our data reveal that regulation of kinesin-1 motility by JIP3 is critical for
axon growth. Together with the recent observation that modulation of dynein’s velocity affects
axon elongation (61), our study underscores the importance of regulation of intracellular
transport for neuronal development.
Binding of JIP3 to KLC enhanced kinesin-1 binding to microtubules in vitro, indicating
that JIP3 likely relieves KLC-based inhibition of KHC-microtubule binding. This is consistent
with previous findings that KLC inhibits binding of KHC to microtubules (19) and that KLC
must be bound by regulatory proteins in order for kinesin-1 to efficiently dock on microtubules
(20). However, the absence of JIP3-KLC binding did not have any effect on axon elongation or
regeneration. One possible reason for this observation is that cargoes associated with KLC might
compensate for loss of JIP3 interaction with KLC. Binding to the tetratricopeptide (TPR) domain
of KLC is sufficient to activate kinesin-1 transport (62) and several neuronal proteins interact
with KLC via its TPR domain, including amyloid precursor protein (63), calsyntenin (64),
alcadein (25) and caytaxin (65). Alternatively, other JIPs may compensate for loss of JIP3-KLC
interactions in cells. Indeed, JNK-interacting protein 1 (JIP1), a protein functionally and
51

structurally related to JIP3, also regulates kinesin-1 microtubule binding and motility (20),
regulates cortical axon development (54) and can partially rescue the axon projection defects
present in JIP3 KO mice (47). Therefore, neurons seem to have multiple means of ensuring
kinesin-1 docking to microtubules.
JIP3 interaction with KHC specifically promoted kinesin-1 motility in our TIRF assay.
This is in agreement with reports that the tail domain of KHC autoinhibits its motility along
microtubules and must be bound by regulatory proteins for efficient motility (14–17, 20).
Exactly how JIP3 regulates kinesin-1 motility remains to be studied, but our stoichiometry
experiments, which show that at least 4 JIP3 molecules bind per KHC dimer, suggest that JIP3
oligomerization may be important. Our finding that neurons cultured from heterozygous JIP3
KO mice show significant axon elongation defects also suggests that the amount of JIP3 protein
is important for its function. Our experiments in neurons further indicate that JIP3 binding to
KHC is a key event for axon growth and elongation.
Previously, we reported that JIP3 lacking both KHC and KLC binding domains fails to
localize to axon tips (5) and subsequently this inability was posited to be responsible for the
failure of JIP3ΔΔ neurons to promote axon elongation (50). However, we show that JIP3ΔKHC,
which is present in axon tips, is defective for axon growth and regeneration. These results
suggest that regulation of kinesin-1 motility by JIP3 rather than its subcellular localization is
important for axonal outgrowth. Our data do not rule out the possibility that the axonal growth
defects of JIP3ΔKHC may be due to compromised ability to serve as a JNK scaffolding protein,
although we think this is unlikely because the KHC and JNK binding domains of JIP3 do not
overlap (5, 66).
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We found that JIP3 promotes axon elongation in mouse hippocampal neurons but not in
mouse DRG neurons, indicating that JIP3 functions differentially in different cell types. In
addition, the effect of JIP3 can also vary between species since JIP3 promotes axon elongation
but not axon branching in mouse hippocampal neurons, whereas it induces both axon elongation
and branching in rat hippocampal neurons. Our findings are consistent with previous work,
which showed that JIP3 promotes axon length in rat hippocampal neurons (50), but reduces axon
length and branching in mouse cortical neurons (49), and restricts axon branching in rat
cerebellar granule neurons (48). The diversity of neuronal responses to JIP3 is probably a
reflection of JIP3’s multiple functions as a JNK scaffolding protein (55, 67–70), a transport
regulator (41, 42, 44), and an axon gatekeeper (43). We propose that different neuronal subtypes
in different species may be selectively sensitive to one or more functional modules of JIP3.
Why does modulation of kinesin-1 motility on microtubules affect axon growth,
especially axon length? A simple explanation is that delivery of trophic cargoes to the axon tip is
disrupted when kinesin-1 motility is disrupted. However, our results are interesting in light of a
recent model of axon length-sensing proposed by Rishal and colleagues (24). This model posits a
frequency-based signaling module, whereby a cell senses the length of an axon based on the
frequency of an oscillating signal sent anterogradely to the axon tip and returned via retrograde
transport. Given that JIP3 associates with both kinesin-1 and dynein during axon growth and
after injury (59, 71–73), JIP3 may be a promising lead to elucidate possible oscillating signaling
modules.
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Materials and Methods
Antibodies and reagents
Rhodamine- and biotin-labeled microtubules were generated as described using porcine
rhodamine- and biotin-tubulin and bovine unlabelled tubulin, all obtained from Cytoskeleton
(Denver, CO). The antibodies used were as follows: anti-MAP2 (Millipore, Temecula, CA), antiTau clone 5E2 (Millipore), anti-SCG10 (Novus, Littleton, CO), anti-JIP3 (Bowman et al., 2000,
Cavalli 2005), anti-GFP (Life Technologies, Grand Island, NY), anti-FLAG (Sigma-Aldrich, St.
Louis, MO), anti-α-tubulin (Abcam, Cambridge, MA), p-cJun (Cell Signaling, Danvers, MA)
and anti-βIII-tubulin (Sigma-Aldrich). JIP3 knockout mice were previously described (Kelkar
2003). CD10 timed pregnant mice were obtained from Charles River Laboratories (O’Fallon,
MO) for isolation of embryonic DRGs. Sprague-Dawley timed pregnant rats were obtained from
Charles River Laboratories for isolation of embryonic hippocampal neurons.
Plasmid construction
KLC-mCit was a generous gift from Dr. Kristen Verhey. FLAG-KHC and EGFP-JIP3 mutants
were described previously (5). Briefly, the cDNA coding sequences were cloned in-frame
downstream of their respective tags in the multicloning sites of pcDNA3 and EGFP-C1 vectors,
respectively. Lentiviral JIP3 constructs were generated by excising the JIP3-EGFP fusion
construct from their C1 vectors and inserting them into the FUGW vector using Age1/EcoR1
cloning sites.
Lentiviral production
Lentiviral particles were concentrated from HEK293T culture medium as described previously
(57). Briefly, HEK293T cells were transfected using Lipofectamine 2000 with the FUGW-JIP3
construct of interest, pVSV-G and dR8.91 in a 1:1:3 ratio according to the manufacturer’s
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specifications (Invitrogen, Grand Island, NY). After 2 days, culture medium was collected and
filtered through a 0.45 µm pore. Filtered culture medium was incubated overnight with Lenti-X
lentiviral concentrator according to the manufacturer’s instructions (Clontech, Mountain View,
CA) and centrifuged at 1,000xg for 45 minutes to pellet lentiviral particles. Pellets were
resuspended in opti-mem before adding to cultures.
In vitro motility assay
In vitro motility assay was performed as described (5, 20) with minor modifications.
COS-7 cells were obtained from ATCC (Manassas, VA) and cultured as recommended. Cells
were transfected using Lipofectamine 2000 (KLC-mCit, all FLAG-JIP3 and EGFP-JIP3
constructs) or Lipofectamine 3000 (FLAG-KHC), both from Invitrogen according to the
manufacturer’s instructions. Twenty-four hours after transfection, COS-7 cells were lysed in
buffer (500 mM PIPES, 1 mM EGTA, 1 mM MgSO4, 0.1% Triton X-100, Roche protease
inhibitor tablet, pH6.9) and supernatant was collected by centrifugation at 16,000xg for 10 min at
4°C. Flow chambers of approximately 20µl volume were assembled by adhering silanized
coverslips to glass slides using double-sided tape. 250 nM rhodamine- and biotin-labeled
microtubules were adhered to the coverslips using 0.01µg/µl streptavidin (Sigma-Aldrich). The
coverslip surface was then blocked with 5% pluronic (Sigma-Aldrich). Motility mix was
generated by adding 5µl FLAG-JIP3 (or untransfected control lysate), 1µl FLAG-KHC, 1µl
KLC-mCit and 1µl 40 mM Na-GTP to 8µl motility assay buffer (10 mM PIPES, 50 mM KOAc,
4 mM MgSO4, 1mM EGTA) supplemented with 1µl 1 M DTT, 1µl oxygen scavenging system
(250µg/µl glucose oxidase, 35µg/µl catalase, and 1µl 4.5mg/mL glucose), and 1µl 0.5 mM taxol.
KLC-mCit molecules were subsequently visualized at 25°C using TIRF microscopy on an
inverted microscope (Olympus IX81). 488 and 532 nm diode-pumped solid-state lasers (Melles
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Griot) were used at 5 mW power to visualize mCit and rhodamine, respectively. Images were
captured at 1s intervals on a back-thinned electron multiplier-CCD camera (ImagEM,
Hamamatsu). KLC-mCit motility was analyzed by kymographs generated and measured in
Slidebook (Intelligent Imaging Innovations). Vertical lines in the kymographs were scored as
nonmotile events, whereas diagonal lines that lasted longer than two frames were scored as
motile events. Only lines with a clear on and off event during the 100s movie were analyzed to
avoid inclusion of aggregates bound to microtubules. We also did not score landing events for
puncta that were unusually bright, since these most likely represent aggregates.
For the KHC dimer experiments in supplement S5, the experimental setup was as above
except 1 µl each WT JIP3-GFP and FLAG-KHC were used. For the stoichiometry experiments,
we modified our dimeric KHC assay by adding AMPPNP instead of Mg-ATP. Since AMPPNP
is non-hydrolyzable, it locks KHC and associated WT JIP3-GFP molecules to the microtubules.
We then photobleached WT JIP3-GFP puncta by applying continuous laser power; this causes
the JIP3-GFP molecules to photobleach randomly, and a unitary photobleaching step can be
determined by measuring the smallest drop in fluorescence intensity. We then calculated the
number of GFP molecules in individual puncta as (initial fluorescence intensity of a puncta –
background fluorescence intensity)/fluorescence intensity of a single GFP molecule.
Cell culture, transfection, staining and image analysis
Hippocampal electroporation and culture
Hippocampuses were isolated from pups and dissociated with papain (Worthington, Lakewood,
NJ) and DNAse for 30 minutes and triturated in neurobasal culture medium supplemented with
B-27 (1%), penn/strep (1%) and L-glutamate (0.25%). Neurons were isolated by centrifugation
and resuspended in electroporation solution. Electroporation was carried out using 5 µg DNA in
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100 µl isotonic solution (2% Buffer I (2 g ATP-disodium salt, 1.2 g MgCl2•6H2O into 10 mL
H2O) into Buffer II (6 g KH2PO4, 0.6g NaHCO3, 0.2 g glucose into 300 mL H2O, pH 7.4))
using an Amaxa Nucleofector II (Lonza, Basel, Switzerland) factory preset for mouse
hippocampal neurons. Neurons were rapidly centrifuged after electroporation and resuspended in
culture medium for plating. Neurons were cultured on poly-D lysine (PDL) coated glass
coverslips that had been etched for 3 hours in nitric acid. Neurons were allowed to grow for 5
days before fixing and staining.
DRG infection and culture
DRG neurons were isolated from e13 mouse pups and dissociated with 0.05% Trypsin-EDTA for
20 minutes. The trypsin was replaced with neurobasal culture media supplemented with B27
(2%), penn/strep (1%), Glutamax (1%), FDU (0.5%) and NGF (0.1%), and neurons were
triturated 25 times with a p1000 pipette tip. Media was removed and neurons were triturated an
additional two cycles. Neurons were resuspended in enough medium to plate 5 µl/10,000 cell
spot and allowed to sit on the PDL- and laminin-coated culture surface for 5 minutes before a
full volume of culture medium was added to the culture surface. For growth assays, neurons
were infected at DIV1 and fixed and stained at DIV3 for alpha tubulin. For injury assays, at 3
DIV neurons were infected with lentiviral JIP3 constructs. At DIV7, neurons were lysed for
western blots or injured with a metal probe. 12h after injury, neurons were fixed and stained for
the axonal regeneration marker SCG10 or βIII-tubulin.
Fixing and staining
Culture media was removed and replaced with 4% phosphate-buffered paraformaldehyde for 15
minutes to fix neurons. Neurons were washed with PBS thrice before blocking in 10% goat
serum/0.1% Triton X-100 in PBS. Primary antibody was diluted in blocking solution and added
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to cultures after 20 minutes. Cultures were washed thrice with PBS before the addition of
secondary antibodies (1:1000). All antibody incubation times were 30 minutes. Cultures were
washed thrice with PBS after secondary antibody incubation before mounting using Prolong
mounting medium (Life Technologies).
Image acquisition and analysis
Images were acquired with fluorescence microscopy (Nikon, Eclipse TE 200-E) and analyzed
using ImageJ. For hippocampal axon morphology, neurites were traced and length was measured
using the NeuronJ plugin. NeuronJ-produced tracings were then used as input for the Sholl
Analysis plugin. For DRG axon regeneration, regeneration index was measured as previously
described (57). Briefly, SCG10 images were thresholded to create a binary image that eliminated
background fluorescence. Then, fluorescence intensity distal to the site of injury was measured
as a percentage of fluorescence intensity proximal to the site of injury for a given area (that is,
fluorescence intensity was measured over an equal sized area for proximal/distal comparisons).
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Figure 1: JIP3 regulates distinct aspects of kinesin-1 motility via differential binding to
KLC and KHC subunits. (A) Schematic representation of the TIRF-based kinesin-1 motility
assay. Rhodamine- and biotin-labeled microtubules (red line) are adhered to coverslips (black
line) with streptavidin. A motility mix with FLAG-JIP3, KLC-mCit and FLAG-KHC protein
lysates is added to the chamber. Since KLC has no intrinsic motility along microtubules, mCit
puncta move along microtubules only when kinesin-1 is functioning as a heterotetramer. (B)
Schematic representation of JIP3 mutants used in this study. JIP3ΔKLC removes aa429-459
corresponding to the KLC binding domain. JIP3ΔKHC removes aa5-81 corresponding to the
KHC binding domain. JIP3ΔΔ removes both the KLC and KHC binding domains. KBD, KHC
Binding Domain; JBD, JNK binding domain, LZ, leucine zipper (KLC binding domain). (C)
Representative western blot of KLC-mCit and FLAG-KHC constructs. FLAG-KHC and KLCmCit were both present in their expected size ranges (n=3). (D) Representative western blot of
FLAG-JIP3 lysates, including a control lysate lacking JIP3, and FLAG-KHC for comparison. 1µl
of each of the JIP3 mutants and control lysate and 3µl of the FLAG-KHC were loaded in the gel.
All JIP3 constructs were expressed at much greater levels than FLAG-KHC. (E) Representative
kymographs from TIRF experiments. Each Y-axis represents 100s of imaging time. Scale bar, 5
µm. (F) Binding frequency was measured as the number of motile and nonmotile binding events
per micron of microtubule. WT JIP3 and JIP3ΔKHC significantly increased the microtubule
binding frequency of kinesin-1 compared to untransfected controls, but JIP3ΔKLC did not. (F-G)
n=74 (control), 93 (WT JIP3), 85 (JIP3ΔKLC) and 92 (JIP3ΔKHC) microtubules analyzed in
four replicates. ANOVA p=1.65x10-5, #p<<0.001 compared to control, Tukey HSD. (G) Motile
efficiency was measured as the number of motile events per 10 microns of microtubule. All JIP3
mutants increased motile efficiency compared to control, but JIP3ΔKHC produced a
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significantly lower motile efficiency than WT JIP3. ANOVA p=0.01, *p<0.05, ***p<0.001
compared to control, Tukey HSD. (H) Velocity of motile events. WT JIP3 and JIP3ΔKLC
significantly increase run speed compared to control, but JIP3ΔKHC did not. (H-K) n=41
(control), 108 (WT JIP3), 80 (JIP3ΔKLC) or 86 (JIP3ΔKHC) motile events in four replicates.
ANOVA p=9.65x10-5, **p<0.01, ***p<0.001 compared to control, Tukey HSD. (I) Run length
of motile events. WT JIP3, JIP3ΔKLC and JIP3ΔKHC all significantly increase run length
compared to controls, but JIPΔKHC does not increase run length to the extent that WT JIP3
does. Kruskal-Wallis p=4.2x10-5, *p<0.05, **p<0.01, #p<<0.001 compared to Velocity, MannWhitney U test. (J) Histogram of the number of GFP molecules in JIP3-GFP bound to FLAGKHC. Counts below 4 were rarely observed, suggesting that JIP3 associates with KHC with at
least 2:1 stoichiometry. (K) Representative trace of the fluorescence intensity over time of a
JIP3-GFP puncta. Fluorescence intensity decreases in distinct steps (red lines), representing
photobleaching of single GFP molecules. The total number of JIP3-GFP molecules can then be
calculated by dividing the overall drop in fluorescence intensity (blue line) by the intensity of a
single GFP molecule. This example shows a puncta that is calculated to contain 4 GFP
molecules.
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Figure 2: JIP3 is required for axon elongation. (A) Representative western blots from JIP3
WT (+/+), het (+/-) and KO (-/-) littermate embryonic whole brain lysates. (B) Quantification of
(A). JIP3 heterozygosity results in an approximately 50% reduction of JIP3 expression compared
to WT. n=5 pups each group, litter-matched. (C) Tau (axons) and MAP2 (dendrites) staining of
littermate WT, het and KO embryonic hippocampal neurons at DIV5. Most neurons produce one
tau-positive axon and multiple MAP2-enriched dendrites. Arrowheads indicate cell bodies,
arrows indicate tip of the longest axon. Scale bar 50µm. (D) Quantification of axon number from
(C). No difference in axon number was detected between any of the groups. Kruskal-Wallis
p=0.22. (D-H) n=100 neurons per group over 2 replicates. (E) Quantification of total axon length
from (C). Het and KO axons are significantly shorter than WT. ANOVA p=0.018, *p<0.05,
**p<0.01 compared to WT, Tukey HSD. (F) Quantification of axon branching from (C) by Sholl
analysis. No differences in axon branching were detected in any of the groups. ANOVA p=0.23.
(G) Total dendrite length quantification of (C). No differences in dendrite length were detected
in any group. ANOVA p=0.81. (H) Dendrite branching quantification of (C) by Sholl analysis.
No difference in dendrite branching was detected in any group. ANOVA p=0.87.
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Figure 3: JIP3 binding to KHC is required to promote axon elongation. (A) Rescue of axon
length defects in JIP3 KO mouse hippocampal neurons by JIP3 WT and mutants shown in
Figure1B. Top panel, tau (axons) and MAP2 (dendrites) staining of mouse JIP3 KO hippocampal
neurons. Bottom panel, EGFP signal produced by the JIP3-EGFP fusion constructs. As in Figure
2C, most neurons extend a single axon. Arrowheads indicate cell bodies, arrows indicate tip of
the longest axon. Scale bar 50µm. (B) Quantification of total axon length from (A). WT JIP3 and
JIP3ΔKLC rescued axon length defects of the JIP3 KO, but JIP3ΔKHC and JIP3ΔΔ did not. (BD) n=59 (Vector), 66 (WT JIP3), 71 (JIP3ΔKLC), 67 (JIP3ΔKHC) or 53 (JIP3ΔΔ) neurons from
3 replicates. ANOVA p=0.065, *p<0.05, **p<0.01 compared to Vector, Tukey HSD. (C)
Quantification of axon branching from (A) by Sholl analysis. No changes in axon branching was
detected amongst any of the groups. ANOVA p=0.35. (D) Total dendrite length quantification
from (A). No change in dendrite length was detected between any of the groups. ANOVA
p=0.25. (E) Dendrite branching from (A) analyzed by Sholl analysis. No change in dendrite
branching was measured between any groups. ANOVA p=0.34.
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Figure 4: Mutations in JIP3-KHC binding are dominant-negative. Analysis of JIP3 deletion
mutants shown in Figure 1B in WT rat hippocampal neurons. (A) WT rat hippocampal neurons
electroporated with the indicated constructs were fixed and stained for tau/MAP3
(axons/dendrites) at DIV5 (top panel). Arrowheads indicate cell bodies, arrows indicate axon
tips. Scale bar 50µm. (B) Total axon length quantification of (A). Expression of JIP3ΔKHC or
JIP3ΔΔ, but not WT JIP3 or JIP3ΔKLC, significantly reduced axon length compared to Vector
controls. (B-E) n=70 (Vector), 68 (WT JIP3), 72 (JIP3ΔKLC), 73 (JIP3ΔKHC) or 66 (JIP3ΔΔ)
neurons from 5 replicates. ANOVA p<<0.001, #p<<0.001 compared to vector, Tukey HSD. (C)
Axon branching quantification by Sholl analysis of (A). Expression of JIP3ΔKHC and JIP3ΔΔ
reduced axon branching, but expression of WT JIP3 or JIP3ΔKLC did not, ANOVA p<<0.001,
#p<<0.001 compared to vector, Tukey HSD. (D) Total dendrite length quantification of (A). No
difference in dendrite length was measured between any groups, ANOVA p=0.42. (E) Dendrite
branching of (A) by Sholl analysis. Expression of JIP3ΔKHC and JIP3ΔΔ significantly reduced
the number of dendrite branches, but to a much smaller extent than axon branches (see 4C),
ANOVA p=2.0x10-4, **p<0.01, Tukey HSD.
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Figure 5: JIP3 binding to KHC is required for axon regeneration. (A) Representative
western blot of spot cultures infected with lentiviral vector, EGFP-tagged WT JIP3, JIP3ΔKLC,
JIP3ΔKHC or JIP3ΔΔ. GFP was used to probe for transgenic JIP3 expression. Note that the gel
used did not allow for resolution of molecular weight changes between mutants and WT. (B)
Axon growth of DRG neurons infected at DIV1 with mutant JIP3 lentivirus and assessed for
axon growth at DIV3. Dotted lines indicate boundary of the cell body spot and the point from
which axon length was assessed. Expression of JIP3 mutants did not affect growth of DRG
neurons. The grid-like overlay is an artifact of stitching images together to visualize the entire
spot field. (C) Quantification of (B). No significant differences in maximum axon projection
from the spot culture boundary were detected between different conditions. n=17 (Vector), 19
(WT JIP3), 24 (JIP3ΔKLC), 21 (JIP3ΔKHC) or 17 (JIP3ΔΔ) fields of view analyzed from 3
replicates (4 spots per group per replicate), ANOVA p=0.30. (D) Representative images of
infected spot cultures 12h after axon injury, stained for the regenerating axon marker SCG10.
Vector-, WT JIP3- and JIP3ΔKLC-infected neurons undergo robust regeneration after injury,
which is markedly reduced with expression of JIP3ΔKHC or JIP3ΔΔ. Dashed lines indicate the
site of injury. Scale bar 100µm. (E) Quantification of (D). WT JIP3 and JIP3ΔKLC slightly, but
not significantly, reduce axon regeneration compared to Vector controls (p=0.077 and 0.088,
respectively). In contrast, JIP3ΔKHC and JIP3ΔΔ attenuate axon regeneration after injury. n=15
(Vector), 18 (WT JIP3), 23 (JIP3ΔKLC), 30 (JIP3ΔKHC), or 31 (JIP3ΔΔ) fields of view
analyzed from 4 replicates (4 spots per group per replicate), ANOVA p=0.002, **p<0.01,
***p<0.001, Tukey HSD. (F) Top two rows: staining of activated phosphorylated cJun (p-cJun)
after axotomy in JIP3 mutant-expressing neurons. All groups display strong nuclear staining of
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p-cJun as indicated with the DAPI counterstain. Bottom row: Uninjured controls display no p-cjun staining.
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Supplemental material
Supplemental video S1: Representative video of kinesin-1 motile events on microtubules in the
presence of untransfected control COS7 lysates. Untransfected control lysates rarely produce
microtubule binding or motile events, and microtubule binding events are short-lived when they
do occur. (Supplemental videos S1-4) First frame shows rhodamine-labeled microtubules, all
subsequent frames show mCit-positive KLC puncta. 100 frames of a 1 FPS video are shown here
at a 7 FPS rate (7x speed). Arrows indicate start points of motile events, arrowheads indicate
nonmotile events. Scale bar 5 µm.
Supplemental video S2: Representative video of kinesin-1 motile events on microtubules in the
presence of WT JIP3 COS7 lysates. Binding events are long-lived and often result in motility.
Motile events are frequently robust, fast and long-lived. Arrows indicate start points of motile
events, arrowheads indicate nonmotile events. Scale bar 5 µm.
Supplemental video S3: Representative video of kinesin-1 motile events on microtubules in the
presence of JIP3ΔKLC COS7 lysates. Binding events are infrequent but often result in motile
events. Motile events are not as long-lived as those produced in the presence of WT lysates, but
are relatively long-lived and fast compared to untransfected controls. Arrows indicate start points
of motile events, arrowheads indicate nonmotile events. Scale bar 5 µm.
Supplemental video S4: Representative video of kinesin-1 motile events on microtubules in the
presence of JIP3ΔKHC COS7 lysates. Binding events are frequent but rarely result in motility.
Motile events are short and slow relative to those produced in the presence of WT JIP3 lysates.
This video shows a looped bundle of two microtubules, hence the motility of the highlighted
event is bidirectional. As nonmotile events are abundant under these conditions, only some are
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highlighted in this video. Arrows indicate start points of motile events, arrowheads indicate
nonmotile events. Scale bar 5 µm.
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Supplemental figure S5: (A) Schematic representation of a KHC dimer experiment. (B) Run
speeds from (A). WT fully activates the KHC dimer to a run speed of 0.25 µm/sec, while
JIP3ΔKHC performs no better than control conditions without added KHC. JIP3ΔKLC partially
activates the dimer. ANOVA p=3.98x10-8, #p<<0.001; (B-C) n=51 (WT), 88 (ΔKLC), 161
(ΔKHC), 46 (-KHC). (C) No difference in run length was detected between any groups.
ANOVA p=0.18. (D) Histogram of velocity data from Figure 1H. (E) Histogram of run length
data from figure 1I.
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Supplemental figure S6: (A) Split channels of images shown in Figure 3A. As in Figure 1, Tau
is restricted to the axon and MAP2 is enriched in the dendrites. (B) Axon number data from
neurons analyzed in Figure 3. No difference in axon number was detected between groups.
p=0.15, Kruskal-Wallis.
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Supplemental figure S7: (A) Split channels of images shown in figure 4A. (B) Axon number
data from neurons analyzed in Figure 4. No difference in axon number was detected between
groups. p=0.08, Kruskal-Wallis.
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Supplemental figure S8: SGC10 as a marker for axon regeneration in JIP3 mutant-expressing
neurons. SCG10 is shown here with a β-III tubulin counterstain. SCG10 is present in the
regenerating axons in all conditions, as shown with the tubulin counterstain. However, SCG10 is
not present in the degenerating axons past the site of injury, highlighted with arrowheads.
Tubulin is present in these degenerating axons and is therefore not an appropriate axon
regeneration marker. Axotomy site indicated with dotted line. Scale bar, 50 µm.
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CHAPTER 3
Neuronal Ran promotes axon elongation by promoting growth
cone filopodial dynamics

This manuscript is being prepared for submission in a peer-reviewed journal by D Watt and V Cavalli.
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Abstract
Axon growth is a critical feature of both neural development and repair. Microtubule
dynamics are critical for axon growth; however the molecular mechanisms governing
microtubule dynamics in developing axons are complex and not fully understood. The small
GTPase Ran, originally characterized as a nucleocytoplasmic trafficking protein, also has roles in
ciliary transport and mitotic spindle formation. Several Ran-dependent cytoskeletal remodelers
active during mitotic spindle formation are also known to control axon cytoskeletal dynamics.
Since Ran is present in developing and adult axons, we explored the possibility that Ran
regulates axon growth by controlling microtubule dynamics. Here we present evidence that
neuronal Ran levels are precisely tuned to promote axon growth. Furthermore, we show that Ran
promotes axon growth by controlling microtubule dynamics in filopodia. Interestingly, we found
that Ran knockdown in sensory neurons plated on and inhibitory substrate that mimics the
environment of the injured central nervous system promotes axon elongation, an effect also
mediated by filopodial dynamics. We also investigated proteins that might modulate Ran
function in the axon, focusing particularly on the only known cytoplasmic Ran guanine exchange
factor, RanBP10. We demonstrate that RanBP10 is enriched in growing axon tips in a Randependent manner and interacts with Ran and tubulin in neurons. RanBP10 knockdown
significantly reduces axon elongation, an effect that is rescued by expression of Ran, suggesting
that RanBP10 promotes axon elongation in a Ran-dependent manner. These results indicate that
Ran is a key player in the modulation of axon elongation and might differentially affect axon
growth in the peripheral and central nervous systems.
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Introduction
Axon growth is a critical feature of neuronal development and repair. In both
development and repair, the structure responsible for axon growth is the growth cone, a
temporary structure that forms at growing axons tips. The growth cone is highly dynamic and
rapidly extends and retracts to explore its environment and propel axon growth. A critical
component of growth cone function is the modulation of cytoskeletal dynamics. The actin-rich
lamellipodium provides mechanical force to propel the plasma membrane forward through an
environment, allowing rapid responses to environmental cues (1, 2). The actin- and microtubulerich filopodia provide a structure on which microtubules can nucleate and mature, directing axon
growth, while maintaining a degree of instability, allowing the growth cone to rapidly change
shape in response to its environment (1, 3, 4). Precision modulation of cytoskeletal dynamics is
therefore critical for axon growth during development and repair.
The small GTPase Ran was originally characterized as a nucleocytoplasmic trafficking
protein. At the nuclear pore, nuclear import and export are driven by local gradients of GTP- or
GDP-bound Ran (5, 6). These local nucleotide-bound Ran gradients are achieved through
selective localization of Ran accessory proteins (7). The guanine exchange factors (GEFs)
generate Ran-GTP, and the primary Ran GEF, RCC1, binds chromatin and is therefore found
exclusively in the nucleus (8, 9). Localization of Ran regulatory proteins is therefore a critical
feature of Ran biology, as it enables local enrichment of Ran-GTP. Recently, the Verhey group
described a Ran-based transport operation at the ciliary port with striking similarities to the
nuclear pore, suggesting that Ran functions in distinct niches based on subcellular enrichment of
Ran-GTP (10, 11). In addition to its role in nucleocytoplasmic and ciliary transport, Ran also
functions as a microtubule modulating protein during mitotic spindle formation (12). During
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mitosis, the nuclear envelope disintegrates, however local enrichment of Ran-GTP around
chromatin is maintained via the chromatin binding feature of RCC1 (9, 13–19). This local
enrichment of Ran-GTP releases microtubule effector proteins from importin-based molecular
sequester and allows stabilization of microtubules specifically around chromatin (20–23). In
addition to distinct local niches, then, the Ran cycle can also have distinct temporal niches,
functioning at the nucleus as a trafficking protein during interphase and a microtubule modulator
during mitotic spindle formation.
Here, we explore the possibility that the axon growth cone is a novel Ran niche, and that
Ran modulates microtubule dynamics in growth cones. Several pieces of evidence make this
hypothesis especially compelling. First, microtubule-stabilizing proteins regulated by the Ran
cycle during mitotic spindle formation also have well-characterized roles in axon elongation.
Adenomatous polyposis coli (APC), for example, promotes microtubule stability during mitotic
spindle formation and modulates microtubule dynamics in growth cones (24–29). Second, Ran
protein is present in adult axons, and Ran mRNA is present in developing axons and growth
cones (30–32). This means that Ran has an opportunity to regulate microtubule dynamics,
although this possibility has not been explored to date. We present evidence here that neuronal
Ran levels are tuned to promote axon elongation, that neuronal Ran modulates filopodial and
microtubule dynamics in growth cones, and that a cytoplasmic Ran GEF is specifically enriched
in growth cones. This evidence is consistent with Ran functioning as a microtubule modulating
protein in growth cones.
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Results
Neuronal Ran promotes axon elongation
To investigate the role of Ran in axon elongation in developing neurons, we modified its
levels in laminin-plated mouse embryonic DRG neurons. These neurons are highly growthcompetent and robustly extend axons (33). We used a spot culture assay as described previously,
plating DRG cell bodies in a “spot” on the growth substrate and allowing axons to extend
radially, which allows us to analyze growth of many axons simultaneously (34). We infected
neurons at DIV1 with control or a murine-specific Ran shRNA, which reduced Ran expression
approximately 70% (Figure 1A-B). At DIV3, control cells extended axons 1375 ± 130 µm.
Compared to control cells, Ran knockdown neurons greatly reduced axon elongation, growing
only 705 ± 57 µm (Figure 1C-D). This effect was completely rescued by expression of human
WT Ran (1278 ± 196 µm), suggesting that the reduction in axon elongation witnessed in Ran
knockdown cells was specific to Ran function. Next, we determined if Ran overexpression
would also modulate axon growth, and infected neurons with lentiviral constructs containing
human WT Ran or vector (Figure 1E). Vector-infected neurons extended their axons 1468 ± 87
µm, comparable to control shRNA-infected neurons. In contrast, WT Ran-infected neurons
extended their axons 1303 ± 70 µm, a small but significant reduction in axon elongation
compared to vector controls (Figure 1F-G). Taken together, these data suggest that neuronal Ran
levels must be properly coordinated to promote axon elongation.
Ran promotes growth cone filopodial and microtubule dynamics
To determine why Ran knockdown neurons reduced axon elongation, we employed live
imaging of axon growth cones. We infected neurons at 6h post-plating with control or Ran
shRNA together with farnesylated EGFP (f-EGFP). Farnesylation robustly localizes proteins to
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the plasma membrane, and allowed us to image the extending growth cones of axons (e.g. 32)
(Figure 2A). On DIV2, we imaged growth cones of neurons and measured the overall rate of
growth cone area change per second to determine how dynamic growth cones were. Control
growth cones were highly dynamic, with a change in growth cone area of 0.99 ± .03 µm2/s. This
is comparable to growth cone area change rates reported previously (34). In contrast, Ran
knockdown reduced the rate of growth cone area change to 0.74 ± 0.03 µm2/s (Figure 2B). We
then determined if Ran knockdown had any effect on filopodial dynamics, since these are the
only motile growth cone structures that contain microtubules and since Ran is known to
modulate microtubule dynamics in other contexts. To this end, we manually tracked filopodia
and measured their speed. Filopodia of control growth cones were highly motile, moving 3.1
±0.7 µm/sec. In contrast, Ran knockdown neurons had much less motile filopodia, averaging a
speed of 2.0 ±0.6 µm/sec (Figure 2C). This suggests that the reduction in axon growth observed
in Ran knockdown neurons can be attributable to a reduction in growth cone and, more
specifically, filopodial dynamics.
While growth cones contain filopodia and lamellipodia, only filopodia contain
microtubules (36). Since we detected changes in filopodial speed in Ran knockdown neurons, we
also measured overall microtubule dynamics using the SiR-tubulin probe, a cell-permeable
marker for microtubules. We measured the overall rate of change of SiR-tubulin positive area as
a function of time to determine if overall microtubule dynamism was changed by Ran
knockdown (Figure 2D). Overall, the SiR-tubulin positive area was less motile than the f-EGFP
positive area, changing at a rate of 0.58 ± 0.02 µm2/s in control neurons (Figure 2E). This is
consistent with growth cone biology, as the cell membrane would change with both lamellipodial
and filopodial dynamics, and since the microtubule cytoskeleton must stabilize to promote cargo
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delivery to growing axon tips. Ran knockdown significantly reduced overall microtubule
motility, eliciting a rate of SiR-tubulin area change of 0.41 ± 0.02 µm2/s. These data are
consistent with Ran functioning in growth cones to, at least in part, modulate microtubule
dynamics.
Ran knockdown promotes axon growth on inhibitory substrates by increasing filopodial
dynamics
Laminin supports axon growth during development, where it functions chemotactically to
promote axon extension. However, environments inhibitory to axon growth are a primary
concern for axon regeneration. After spinal cord injury, an inflammatory glial scar forms which
blocks axon regeneration, partially via enrichment of chondroitin sulfate proteoglycans, CSPGs
(37–40). We therefore decided to test whether neuronal Ran also supported axon growth on
CSPG-coated substrates. To this end, we plated embryonic DRG neurons on substrates coated
with CSPG. For this experiment we employed dissociated cultures since spot cultures did not
adhere to the CSPG-coated substrates, CSPG potently inhibited axon outgrowth, reducing axon
length approximately 90% (77 ± 10 µm) compared to laminin-plated neurons (Figure 3A-B).
Unexpectedly, neurons infected with Ran shRNA had longer axons than control shRNA-infected
neurons (195 ± 24 µm). This effect was mitigated by expression of WT Ran (50 ± 15 µm),
indicating that Ran specifically inhibits axon elongation on CSPG-coated substrates.
To determine how Ran knockdown promotes axon growth on inhibitory substrates, we
performed live imaging of axon tips growing on CSPG using microfluidic chambers to pattern
CSPG coating. Live imaging dishes were plated with PDL before adhering microfluidic
chambers. Then, laminin and CSPG were coated on different sides of the microfluidic device via
differential osmotic pressure. Cell bodies were plated on the laminin-coated side of the device to
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promote neuronal survival and axon extension onto the CSPG-coated side. At DIV1, neurons
were co-infected with f-EGFP and control or anti-Ran shRNA. At DIV4, all axons extending into
the CSPG compartment were imaged, unless they were undergoing degeneration, marked by a
fragmentation of the axon f-EGFP signal. Growth cones on these axons were largely immobile,
and never displayed lamellipodia (Figure 3C). The rate of growth cone area change in control
neurons was 0.27 ± 0.01 µm/sec, a reduction compared to laminin controls of approximately
75% (Figure 3E). Filopodial tracking indicated that CSPG coating reduced filopodial speed to
0.03 ± 0.002 µm/sec, compared to more than 3 µm/sec on laminin-coated substrates (Figures 2C,
3F). This dramatic reduction in filopodial displacement on CSPG versus laminin correlates well
with the reduction in axon elongation, and is likely partially responsible for that phenotype.
Importantly, knockdown of Ran partially mitigated the growth cone and filopodial
dynamics phenotype induced by CSPG substrates. In contrast to control neurons, on CSPG Ran
knockdown neurons exhibited a 0.38 ± 0.03 µm rate of growth cone area change, a significantly
greater rate of area change than control-infected neurons. Filopodial speed of Ran knockdown
growth cones on CSPG were more than double that of control-infected neurons, averaging 0.08 ±
0.005 µm/sec. In addition to increasing filopodial dynamics, we also observed a number of
filopodial faults in Ran knockdown cells plated on CSPG, which were present at lower
frequencies in control shRNA neurons (Figure 3D). For our purposes, a filopodial “fault” was a
notable morphological change in a CSPG-plated filopodium, which were rarely observed in
filopodia of laminin-plated neurons. Specifically, we observed buckling, splitting and
degeneration of filopodia, as well as basal motility in some filopodia (that is, the tip of the
filopodium was stationary but the base of the filopodium moved along the body of the axon, a
reversal of the usual motile pattern). All of these faults were more prevalent in Ran knockdown
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(93% of filopodia display a fault) than control neurons (84%), suggesting an abnormality in
filopodial dynamics was responsible for the increase in filopodial dynamics and, concomitantly,
axon elongation. This, coupled with the fact that only MT-rich filopodia and never actin-rich
lamellipodia were observed in CSPG-plated growth cones, suggests that the increase in axon
elongation observed in Ran knockdown neurons on CSPG is at least partially attributable to
changes in microtubule dynamics.
RanBP10, a cytoplasmic Ran GEF, is enriched in growing axon tips in a Ran-dependent
manner
Ran cycles between its inactive GDP-bound state and its active GTP-bound state via its
accessory proteins, the GAPs and the GEFs. While multiple Ran GAPs exist, only two Ran GEFs
have ever been reported. Of those, RCC1 is restricted to the nucleus, but RanBP10 is known to
function in the cytoplasm (14, 41). Furthermore, RanBP10 mRNA is present in embryonic axons
and growth cones (31, 32). We therefore decided to investigate if RanBP10 is present in neurons,
and whether it interacts with Ran to regulate axon growth. First, we used a RanBP10 antibody to
investigate its distribution in neurons. RanBP10 was present in neurons, and especially at axon
tips and in the soma (Figure 4A and data not shown). In contrast, RCC1 was only present in the
nucleus (data not shown). We compared RanBP10 expression to the f-EGFP tag, which localizes
to cell membranes. Theoretically, f-EGFP should be evenly distributed throughout the cell
membrane, and not specifically enriched at axon tips. Compared to this neutral membrane
marker, RanBP10 was enriched approximately 80% specifically at axon tips (Figure 4B). This
suggests that active Ran-GTP is produced at growing axon tips, where it might regulate Ran
function.
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In megakaryocytes, Ran and RanBP10 interact with tubulin to regulate platelet formation
and shape (41–43). Therefore, we also investigated whether Ran and RanBP10 might interact
with cytoskeletal components to regulate axon shape in neurons. To this end, we employed a
reciprocal coimmunoprecipitation using anti-Ran and anti-RanBP10 antibodies in cultured
embryonic DRG neurons (Figure 4C). In DIV8 neurons, Ran and RanBP10 reciprocally
coimmunoprecipitated, suggesting that Ran and RanBP10 indeed interact in neurons.
Furthermore, Ran and RanBP1 antibodies also coimmunoprecipitated tubulin, suggesting that
Ran, RanBP10 and tubulin exist in a complex in neurons. These data are consistent with
RanBP10 functioning as a link between Ran and microtubule dynamics, perhaps by acting as a
GEF to produce active Ran in axon tips. To further explore the relationship between Ran and
RanBP10 in neurons, we measured Ran and RanBP10 distribution in Ran knockdown neurons.
Ran is slightly enriched at the growing tips of axons, however this enrichment is significantly
reduced in Ran knockdown neurons (Figure 4D-E). Interestingly, Ran knockdown increased
growth cone enrichment of RanBP10 (Figure 4F-G). These data are consistent with Ran
regulating the retrograde transport of RanBP10, similar to its role in importin-β mediated
retrograde injury transport (30).
RanBP10 promotes axon growth in a Ran-dependent manner
We next decided to see if axonal RanBP10 had any functional significance. To this end,
we expressed a RanBP10 shRNA in embryonic DRG neurons. In these neurons, expression of
the RanBP10 shRNA reduced RanBP10 expression approximately 50%. Concomitantly, axon
elongation was reduced from 1828 ± 81 µm in control-infected neurons to 1557 ± 138 µm in
shRBP10-infected neurons, a small but significant effect. Interestingly, this reduction in axon
elongation could be rescued completely with expression of WT Ran (1860 ± 140 µm, compared
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to 1640 ± 131 µm in Vector-infected knockdown neurons). This suggests that RanBP10 regulates
axon elongation in a Ran-dependent manner. We also investigated whether RanBP10 modulates
axon elongation of CSPG-coated substrates, and to that end repeated our dissociated culture
experiments described above. On CSPG-coated substrates, RBP10 knockdown did not promote
axon elongation compared to control neurons (203 ± 57 µm in control neurons versus 139 ± 14
µm in RanBP10 knockdown neurons), consistent with RBP10 functioning upstream of Ran in
axons. Taken together, these data are consistent with RanBP10 acting as a Ran GEF.
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Preliminary Data
In addition to investigating the effect of Ran knockdown on neurons, I have also
completed preliminary studies using nucleotide-locked Ran mutants. RanT24N loses its ability to
release a spent GDP, locking it in its GDP-bound state. RanL43E loses its ability to hydrolyze
GTP to GDP, locking it in its GTP-bound state. Since Ran function is dependent on local
enrichment of Ran-GTP or –GDP, overexpressing nucleotide-locked mutants can bias the system
towards one binding state or the other, changing Ran biology in a more subtle way than wholecell knockdown. For these data, it is important to keep in mind that only Ran-GTP has known
binding partners, and is therefore referred to as “active” Ran.
Nucleotide-locked Ran mutants differentially effect axon branching and elongation
I used dissociated DRG cultures to investigate nucleotide binding state-dependent Ran
effects, since subtleties in axon branching patterns are easier to see in these cells (preliminary
Figure 1). Dissociated embryonic DRGs grow in a characteristic pattern, extending two axons
approximately 1-1.5 mm before generating terminal branching arbors with short axon branches.
In vector infected neurons, the longest axon grew approximately 1475 ± 89 µm and 74% of
neurons underwent terminal branching. Nucleotide-locked Ran mutants all localized to the axon
as well as the soma, as evidenced by their EGFP tags presence there (data not shown) Expression
of Ran-GDP, which cannot bind effector proteins, reduced axon elongation (1195 ± 81 µm) and
branching (63% terminally branch), suggesting that active Ran-GTP supports both of these
activities. Indeed, expression of Ran-GTP had no effect on terminal axon branching (69%), but
curiously reduced the length of the longest axon (1163 ± 79 µm). Upon further examination,
Ran-GTP expression increased the mode of axonal branch points (5 versus 3 for vector control)
and decreased the length to the first branch point (582 ± 73 µm versus 828 ± 83 µm for vector
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control). This suggests that an overabundance of Ran-GTP causes ectopic axon branching, which
reduces elongation of the longest axon when the neuron expends resources to elongate secondary
branches. WT infected neurons had no effect on axon elongation (1335 ± 88 µm), but
significantly reduced the incidence of terminal axon branching (55%). I posit that overexpression
of WT Ran partially mimics overexpression of Ran-GDP: if the axonal Ran GEF nears maximal
activity in control neurons, then an abundance of WT Ran would bias the system towards RanGDP. The specific and differential effects of nucleotide-locked Ran mutants on axon shape
support the fact that Ran acts locally within the axon to control growth: since axon growth was
largely intact but exhibited subtle differences between the nucleotide-locked mutants, we doubt
that large scale misregulation of nucleocytoplasmic transport is occurring in these neurons.
Taken together, these data suggest that Ran-GTP is the primary actor in axon growth cones.
Ran-GTP, but not Ran-GDP, rescues Ran knockdown
To validate if Ran-GTP is critical for axon growth, I employed the spot culture assay
described above and determined which nucleotide-locked Ran mutants rescued the axon
elongation defects of Ran knockdown (preliminary Figure 2). As demonstrated previously, Ran
knockdown reduced axon growth significantly (705 ± 57 µm) compared to control neurons (1376
± 131 µm), and WT Ran expression rescued this effect (1279 ± 196 µm). Expression of RanGTP (1743 ± 238 µm) enhanced axon elongation beyond control levels, and Ran-GDP (974 ±
166 µm) failed to completely rescue knockdown of Ran, consistent with the conclusion that
active Ran-GTP is necessary for axon elongation. Furthermore, these data also support the
conclusion that Ran functions in an axonal niche distinct from its nucleocytoplasmic transport
niche. Ectopic Ran-GTP would be produced in the cytoplasm, but Ran is transported into the
nucleus only in its GDP-bound state. Therefore any large-scale nucleocytoplasmic trafficking
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defects caused by whole-cell Ran knockdown would be unlikely to be rescued by Ran-GTP,
since ectopic Ran-GTP would be unable to dynamically relocalize as necessary for the
nucleocytoplasmic trafficking cycle. This strongly suggests that Ran-GTP specifically promotes
axon elongation when it is localized to the axon.
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Discussion
Here, we present evidence that Ran promotes axon elongation. First, we demonstrate that
neuronal Ran levels are tuned to promote axon elongation on permissive substrates, as
knockdown or overexpression of Ran on laminin reduces axon elongation. We trace these effects
to changes in filopodial dynamics, as a Ran shRNA-induced reduction in filopodial speed and
motility correspond to an overall reduction in growth cone dynamism and axon elongation. This
effect is at least partially attributable to changes in microtubule dynamics, as dynamics of the
microtubule-specific SiR-tubulin probe were also reduced by Ran knockdown. Interestingly, Ran
knockdown has the opposite effect on the inhibitory substrate CSPG, where it promotes axon
elongation. Again, filopodial dynamics are altered on CSPG, where Ran seems to increase axon
elongation by increasing filopodial motility and speed. Finally, we demonstrate that the only
known cytoplasmic Ran GEF, RanBP10, is enriched in growth cones, where it promotes axon
elongation in a Ran-dependent manner. These data are an exciting preliminary look into the
possibility that the axon might be a distinct Ran niche. Functional Ran niches have two defining
characteristics: local enrichment of Ran-GTP or –GDP, accomplished by the localization of Ran
GAPs and GEFs; and the release of proteins from karyopherin-based molecular sequester.
Our data do not specifically conclude whether Ran-GTP or –GDP is locally enriched in
subcompartments of the axon. However, the enrichment of RanBP10 in growth cones suggest
that Ran-GTP might be generated there and locally enriched compared to Ran-GDP.
Interestingly, the existence of a Ran-RanBP10-tubulin complex raises the possibility that RanGTP might be specifically enriched near RanBP10-bound microtubules, and selectively stabilize
them via effector proteins. Indeed, the Ran-regulated protein APC promotes stability of
microtubules in growth cones, and also regulates the actin/microtubule interface (27–29, 44–47).
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Although APC is understood as a Ran-regulated protein during mitotic spindle formation, it is
unknown if its activity is Ran-dependent in the axon. It would be interesting to see APC or other
proteins with dual mitotic spindle/growth cone functions are regulated by Ran in both contexts.
We are currently performing experiments to determine if Ran nucleotide binding state is locally
and dynamically regulated in growth cones.
Our data also do not determine whether Ran releases proteins from karyopherin-based
sequester. However, some evidence exists which supports this conclusion. First, as stated above,
proteins known to be regulated by Ran to promote microtubule stability in the mitotic spindle are
present and active in the axon growth cone. Second, karyopherin mRNA, including importin-β
mRNA, is present in embryonic growth cones and axons, suggesting that their proteins might be
present there as well (31, 32). Furthermore, importin-α was shown to controls axon pathfinding
and synaptic bouton number in Drosophila larva (48). These data, combined with our live
imaging results, are consistent with Ran functioning locally to control microtubule dynamics.
While filopodial “faults” were not observed in laminin-plated growth cones of control
knockdown neurons, their occurrence was significantly increased compared to control neurons
when Ran was knocked down in CSPG-plated neurons. The filopodial fault phenotype is
significant because filopodia are the motile growth cone subcompartment that contain
microtubules, in contrast to lamellipodia (36). Since we only ever observed filopodia on CSPG,
and since these filopodia displayed the greatest number of morphological abnormalities, it is
quite possible that modifications of neuronal Ran effect growth cone microtubule dynamics.
Indeed, our SiR-tubulin live imaging on laminin-coated substrates attributes at least part of the
growth cone motility phenotype to microtubule dynamics. These data are consistent with a model
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wherein local generation of Ran-GTP by RanBP10 in the growth cone controls microtubule
dynamics by releasing effector proteins from karyopherin-based molecular sequester.
A primary limitation of the experiments presented here is that they do not distinguish
axonal and somatic Ran functions. After all, a critical function of Ran in any nucleated cell is to
regulate nucleocytoplasmic trafficking; how can we then be sure that the effects we note in, for
example, whole cell Ran knockdown are not attributable to changes in nucleocytoplasmic
trafficking? We think it is unlikely that the effects noted here are exclusively due to changes in
nucleocytoplasmic trafficking. First, while we do see dramatic changes in axon elongation in
Ran knockdown neurons, the cells are remarkably healthy, not only surviving but reliably
generating axons, a highly complex task. Recent studies have linked amyotrophic lateral
sclerosis to inhibition of nucleocytoplasmic trafficking (49–51). These models suggest that
elongated transcripts physically block nucleocytoplasmic trafficking, leading to
neurodegeneration. Since our Ran knockdown neurons show no signs of degeneration as late as
DIV8, and since Ran knockdown would presumably alter nucleocytoplasmic trafficking more
acutely than the slow buildup of aberrant transcripts, we think these effects are at least partially
attributable to axonal, not somatic, Ran. Furthermore, immunocytochemical analysis of our Ran
knockdown neurons confirms that while axonal and growth cone Ran levels are reduced, somatic
Ran levels are maintained in these neurons (Figure 4 and data not shown). Finally, we present
data here that RanBP10, the only known cytoplasmic Ran GEF, is enriched specifically in
growth cones. RanBP10s only known function outside of the neurons is to regulate platelet
formation in megakaryocytes, a Ran-dependent function (41–43). We think it is unlikely that
neurons specifically localize this microtubule-associated Ran GEF to growing axon tips if its
function isn’t at least partially to produce Ran-GTP or control cytoskeletal dynamics there. Still,
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we are currently exploring ways to manipulate Ran expression specifically in the axon or soma
to more conclusively address this limitation.
One exciting possibility that our data raises is that Ran might perform distinct functions
in the axon depending on the temporal needs of the axon. Our data are consistent with a model
wherein Ran promotes microtubule stability locally in the growth cone. What might Ran be
doing in the adult axon, where we know its mRNA is present and it is primarily GTP-bound, at
least in healthy axons? The Fainzilber group developed an elegant model wherein Ran-GTP in
the adult axon acts as a brake on an importin-based retrograde injury signaling complex (30).
After injury, RanGAP mRNA is rapidly transcribed, and Ran-GTP is converted to Ran-GDP,
releasing the retrograde injury signaling complex, which transports NLS-containing injury
signals to the cell body, which responds by activating a pro-regenerative transcriptional program.
In this model, newly converted Ran-GDP remains in the growth cone. It is possible that a
delayed trafficking of RanBP10 in the growth cone might then reestablish the microtubuleregulating Ran role. A delayed enrichment of RanBP10 could be achieved by upregulation of
RanBP10 mRNA or increased translation of RanBP10 mRNA after injury. Indeed, increased
translation of specific transcripts after injury is common in the axon (30, 52, 53) Our data lay the
groundwork for the exciting possibility that the axon is a distinct Ran niche, which modifies
canonical Ran function to novel ends during development, in the adult axon and after axon
injury.
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Materials and Methods
Antibodies and reagents
The antibodies used were as follows: anti-Ran (mouse BD Biosciences, San Jose CA; Rabbit
Abcam, Cambridge MA), anti-α-tubulin (Abcam), anti-RanBP10 (ProSci, Poway CA), anti-IgG
(Abcam), anti-βIII-tubulin (Sigma-Aldrich, St. Louis, MO), anti-H3 (Abcam). CD10 timed
pregnant mice were obtained from Charles River Laboratories (O’Fallon, MO) for isolation of
embryonic DRGs.
Plasmid construction
Ran shRNA and RanBP10 shRNA were selected from a panel of five shRNAs per gene provided
by the McDonnel Genome Institute at Washington University in St. Louis. Farnesylated EGFP
was a generous gift from Naren Ramanan (Indian Institute of Science) and was cloned into a
lentiviral vector using AgeI and EcoRI restriction sites. WT Ran was a generous gift from Jon
Lane (University of Bristol) and was cloned into a lentiviral vector using BamHI and AgeI
restriction sites.
Lentiviral production
Lentiviral particles were concentrated from HEK293T culture medium as described previously
(34, 54). Briefly, HEK293T cells were transfected using Lipofectamine 2000 with the FUGWJIP3 construct of interest, pVSV-G and dR8.91 in a 1:1:3 ratio according to the manufacturer’s
specifications (Invitrogen, Grand Island, NY). After 2 days, culture medium was collected and
filtered through a 0.45 µm pore. Filtered culture medium was incubated overnight with Lenti-X
lentiviral concentrator according to the manufacturer’s instructions (Clontech, Mountain View,
CA) and centrifuged at 1,000xg for 45 minutes to pellet lentiviral particles. Pellets were
resuspended in opti-mem before adding to cultures.

102

Cell culture, transfection, staining and image analysis
DRG culture and infection
DRG neurons were isolated and cultured as previously described (54). Briefly, DRG neurons
were isolated from e13 mouse pups and dissociated with 0.05% Trypsin-EDTA. Neurons were
plated in neurobasal culture media supplemented with B27 (2%), penn/strep (1%), Glutamax
(1%), FDU (0.5%) and NGF (0.1%). Neurons were plated on substrates coated in poly-D lysine
and either laminin 3.3 µg/mL (ThermoFisher, Grand Island NY) or chicken whole nervous
system CSPG at 1.5 µg/mL (Millipore). Spot culture assays were plated in media at a
concentration of 5 µl/10,000 cells and allowed to sit for 5-15 minutes before the full volume of
plating media was added, and neurons were infected at DIV1 and fixed and stained at DIV3 for
α-tubulin. Dissociated cultures were resuspended in full plating medium volume before plating.
For staining of endogenous proteins, neurons were fixed at DIV1 (untransfected) or infected at
DIV1 and fixed at DIV2. For expression analysis by western blot, neurons were infected at DIV1
and fixed at DIV3.
Fixing and staining
Culture media was removed and replaced with 4% phosphate-buffered paraformaldehyde for 15
minutes to fix neurons. Neurons were washed with PBS thrice before blocking in 10% goat
serum/0.1% Triton X-100 in PBS. Primary antibody was diluted in blocking solution and added
to cultures after 20 minutes. Cultures were washed thrice with PBS before the addition of
secondary antibodies (1:1000). All antibody incubation times were 30 minutes. Cultures were
washed thrice with PBS after secondary antibody incubation before mounting using Prolong
mounting medium (Life Technologies).
DRG live imaging
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DRG neurons were dissociated and plated on live imaging dishes as described above. At 6h postplating, neurons were infected with f-EGFP virus. At DIV1, neurons were infected with ctrl or
Ran shRNA. For SiR-tubulin experiments, SiR tubulin reagent was suspended in plating media
and added to neurons at 1 µm 2h prior to imaging on DIV2. Images were acquired using
fluorescence microscopy (Nikon, Eclipse TE 200-E) and analyzed using ImageJ. Images were
acquired every 3s over a 5-10min imaging timeframe for each movie. The Δ area per time was
calculated as described previously (34). Briefly, images were thresholded and the magic wand
tool was used to calculate growth cone area for each movie frame. Microtubule motility of the
SiR-tubulin probe was analyzed similarly. Filopodial tracking was performed manually using the
Manual Tracking plugin for ImageJ.
For CSPG live imaging, neurons were plated using microfluidic chambers (Xona Microfluidics,
Temecula, CA), since the CSPG caused DRGs to fail to adhere to the live imaging dishes. Live
imaging dishes were coated with PDL before adhering the microfluidic device according to the
manufacturer’s specifications. Then, laminin and CSPG were coated on opposite sides of the
chambers in different volumes to generate osmotic pressure and coating specificity. Neurons
were plated on the laminin side and infected at DIV1. Live imaging was performed at DIV4.
Despite plating 10,000 neurons in each device, fewer than 10 axons were detected on the CSPG
side of the device, and so all available growth cones were analyzed in each of two replicates.
Image acquisition and analysis
Cellular images were acquired via fluorescence microscopy and analyzed using ImageJ. For
dissociated cultures, axon length was analyzed using the NeuronJ plugin. For RanBP10 line
scans (Figure 4A-B), the tip of the axon was traced using the segmented line tool and RanBP10
intensity was normalized to f-EGFP intensity. For Ran and RanBP10 growth cone intensity
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(Figure 4D-G), the growth cone was defined as the point where the tubulin stain splayed. A box
was drawn around the growth cone at this point, and Ran or RanBP10 intensity was normalized
to βIII-tubulin intensity.
Coimmunoprecipitation
Coimmunoprecipitation was carried out using rabbit αRanBP10 and mouse αRan antibodies,
with mouse αIgG serving as a negative control. We used Dynabeads protein G-coupled magnetic
beads (Millipore, Temecula CA) according to the manufacturers’ protocol. We also employed a
BS3 crosslinking step for the RanBP10 coimmunoprecipitation to eliminate IgG bands on the
western blot, since only rabbit RanBP10 antibodies are commercially available. BS3 crosslinking
reagent (Millipore) was used according to manufacturer’s specifications. For input,
approximately 100 DIV8 DRG spot cultures were collected and split evenly between the three
immunoprecipitations (approx. total lysate volume: 1mL).
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Figures
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Figure 1: Neuronal Ran promotes axon elongation. (A) Representative blot of DRG cultures
infected with control or Ran shRNA. (B) Quantification of (A). Ran knockdown reduced
neuronal Ran levels approximately 70%. Error bars ± S.E.M, n=3 replicates. (C) Representative
images of DRG spot cultures infected with the indicated constructs. The bars across the image
(and all spot culture images) are an artifact of stitching together multiple images. Scale bar 100
µm. (D) Quantification of (C). The ten longest axons were measured from the nearest edge of the
spot. Ran shRNA reduced axon elongation approximately 50%, an effect which was rescued
with expression of human WT Ran. Error bars ± S.E.M., ANOVA p<<0.001, #p<<0.001 Tukey
HSD, n=12 (ctrl shRNA), 6 (Ran shRNA + Vector) or 8 (Ran shRNA + WT Ran) spots analyzed
over three replicates. (E) Representative western blot of DRG cultures infected with vector or
human WT Ran. The top band in the Ran blot is the GFP-Ran fusion construct, the bottom band
is endogenous Ran. n=2. (F) Representative images of DRG spot cultures infected with GFP
vector or WT Ran. Scale bar 100 µm. (G) Quantification of (F). Ran overexpression reduced
axon elongation slightly, but significantly. Error bars ± S.E.M., #p<<0.001 Student’s t-test, n=4
spots per group over two replicates.
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Figure 2: Ran knockdown reduces growth cone filopodial and microtubule dynamics. (A)
Representative time projections of growth cones imaged with f-EGFP over five minutes. In these
images, all images from the movie were collapsed, so a larger area indicates more motility and
not necessarily a larger growth cone. Scale bar 5 µm. (B) Overall growth cone motility was
measured as the rate of area change per time calculated from (A). A greater rate of area change
per time indicates a more motile growth cone. Error bars ± S.E.M., #p<<0.001 Student’s t-test,
n=11 (ctrl shRNA), 9 (Ran shRNA) growth cones analyzed over 3 replicates. (C) Filopodial
speed measured by manually tracking filopodia in (A). The first five filopodia in each growth
cone was analyzed or, if fewer than five filopodia were present in a video, all filopodia were
analyzed. Ran knockdown significantly reduced filopodial speed. Error bars ± S.E.M.,
#p<<0.001 Student’s t-test, n=60 (ctrl) or 52 (Ran shRNA) filopodia analyzed over two
replicates. (D) Representative still images of SiR-tubulin stain in f-EGFP transfected neurons.
The SiR-tubulin signal is never detected outside the f-EGFP positive cell membrane. (E)
Quantification of microtubule motility in (D). The change in area for the SiR-tubulin signal was
significantly reduced in Ran knockdown cells, indicating a reduction in microtubule motility.
Error bars ± S.E.M., #p<<0.001 Student’s t-test, n=9 (ctrl shRNA), 10 (Ran shRNA) growth
cones analyzed over two replicates.
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Figure 3: Ran knockdown promotes filopodial motility and axon growth on CSPG-coated
substrates. (A) Representative images of DIV3 DRG neurons plated on CSPG and infected with
the indicated constructs. Scale bar 50 µm. (B) Quantification of axon length in (A). Neurons
extended their axons much further when Ran was knocked down compared to control cells, and
this effect was rescued with expression of WT Ran. Error bars ± S.E.M., ANOVA p<<0.001,
#p<<0.001, n.s., not significant, Tukey HSD, n=121 (ctrl shRNA), 116 (Ran shRNA + Vector),
10 (Ran shRNA + WT Ran) neurons analyzed over three replicates. (C) Representative time
projections of growth cones imaged with f-EGFP over five minutes, as in Figure 2A. Scale bar 5
µm. (D) Representative filopodial faults from (C), and a quantification of the incidence of each
fault. Ran knockdown neurons were more likely to display filopodial faults than their control
counterparts. **p<0.01, Chi square test. (E) Overall growth cone motility measured from (C) as
the rate of area change per time was reduced approximately tenfold compared to laminin-plated
neurons (compare to Figure 2B), but Ran knockdown partially rescued this phenotype. Error bars
± S.E.M., #p<<0.001 Student’s t-test, n=14 (ctrl) or 8 (Ran shRNA) growth cones analyzed over
two replicates. (F) Filopodial speed measured from (C) using manual tracking. Filopodial speed
was reduced on CSPG approximately 100-fold compared to laminin-plated neurons (Figure 2C),
but was significantly increased in Ran knockdown cells compared to controls. . Error bars ±
S.E.M., #p<<0.001 Student’s t-test, n=71 (ctrl) or 40 (Ran shRNA) filopodia analyzed over 2
replicates.
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Figure 4: Ran BP10 is enriched in growth cones in a Ran-dependent manner. (A)
Representative images and line traces of RanBP10 in axon growth cones. Top panel, f-EGFP
signal, middle panel, RanBP10 intensity (shown as a heat map), traces, RanBP10 signal
corrected for f-EGFP signal in arbitrary units. RanBP10 is consistently enriched in axon tips.
Scale bar 5 µm. (B) Quantification as in (A), averaged across neurons. RanBP10 is enriched
approximately 80% at the axon tip compared to the axon. Error bars ± S.E.M., n=40 neurons
over two replicates. (C) Coimmunoprecipitation of cultured DRG lysates using RanBP10, Ran or
IgG (negative control) antibody. While RanBP10 is not very abundant in neurons, both RanBP10
and Ran antibodies robustly immunoprecipitate endogenous RanBP10. Ran is also inefficiently
immunoprecipitated by both RanBP10 and Ran antibodies, which is expected based on its
abundance in the soma. Interestingly, a small quantity of tubulin is also specifically
coimmunoprecipitated by both RanBP10 and Ran, suggesting that these proteins exist in a
complex in neurons. Representative western blot from 2 replicates. (D) Ran staining in growth
cones of control and Ran knockdown cells. Ran is slightly enriched in growth cones of control
cells, but is mostly absent from growth cones of Ran knockdown cells. Scale bar 5 µm. (E)
Quantification of (D). Ran knockdown significantly reduces Ran staining, correcting for growth
cone size with βIII-tubulin counterstain. Error bars ± S.E.M., **p<0.01 Student’s t-test, n=20
growth cones analyzed per group over 1 replicate. (F) RanBP10 enrichment in growth cones is
increased in Ran knockdown cells. Scale bar 5 µm. (G) Quantification of (F). Ran knockdown
increases RanBP10 localization to the growth cone, implying a Ran-dependent transport
mechanism for RanBP10. Error bars ± S.E.M., **p<0.01 Student’s t-test, n=60 growth cones
analyzed per group over 3 replicates.
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Figure 5: RanBP10 promotes axon elongation in a Ran-dependent manner. (A)
Representative western blot of DRG lysates infected with control or RanBP10 shRNA. (B)
Quantification of (A). RanBP10 shRNA reduced expression approximately 50%. Error bars ±
S.E.M. (C) Representative images of spot cultures infected with the indicated constructs.
RanBP10 knockdown reduces axon elongation, and interestingly this effect is rescued by
expression of WT Ran. Scale bar 100 µm. (D) Quantification of (C). That RanBP10 can be
rescued by expression of WT Ran suggests a Ran-dependent role for RanBP10 in promoting
axon elongation. Error bars ± S.E.M., ANOVA p<<0.001, #p<<0.001 Tukey HSD, n=10 (ctrl
shRNA), 6 (RanBP10 shRNA), 7 (RanBP10 shRNA + Vector or + WT Ran) spots analyzed per
group over two replicates. (E) Representative images of control and RanBP10 knockdown
neurons plated on CSPG. Scale bar 50 µm. (F) Quantification of axon length from (G). RanBP10
knockdown did not affect axon elongation on CSPG, again suggesting a Ran-dependent role for
RanBP10 in axon elongation. Error bars ± S.E.M., n.s., not significant Student’s t-test, n= 70
(ctrl) or 35 (RanBP10 shRNA) neurons analyzed per group over two replicates.
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Preliminary Figure 1: Neuronal Ran promotes axon branching and elongation in a
nucleotide binding-state dependent manner. (A) Representative images of dissociated DRG
neurons expressing the indicated construct. Scale bar 100 µm. (B) Quantification of the length of
the longest axon in (A). Axon elongation is significantly reduced by expression of Ran-GTP or
Ran-GDP. ANOVA p=0.03, *p<0.05, **p<0.01 Tukey HSD, n=89 (ctrl) 91 (WT Ran, RanGTP) or 96 (Ran-GDP) neurons analyzed over three replicates. (C) Quantification of axon
terminal branching from (A). Expression of WT Ran or Ran-GDP reduces the percentage of
neurons undergoing terminal branching. **p<0.01, #p<<0.001, Chi square test, n as in (B). (D)
Quantification of branch number from (A). Expression of Ran-GTP significantly increased
branch number compared to control. *p<0.05, Mann-Whitney U-test following KalmogarovSmirnov test for normality, n as in (B). (E) Quantification of length to first branch point from
(A). Expression of Ran-GTP caused premature ectopic branching. ANOVA p=0.11, *p<0.05
Tukey HSD, n as in (B).
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Preliminary Figure 2: Ran-GTP promotes axon elongation. (A) Representative images of
nucleotide-locked Ran mutants in a Ran shRNA background. Scale bar 100 µm. (B)
Quantification of (A). While expression of WT Ran rescued Ran knockdown, but expression of
Ran-GDP did not. Interestingly, expression of Ran-GDP increased axon elongation above
control levels, implying that a high relative Ran-GTP concentration promotes axon elongation.
ANOVA p<<0.001, #p<<0.001 compared to control Tukey HSD, n=12 (ctrl), 8 (Ran shRNA
+WT Ran), 7 (Ran shRNA +Ran-GDP), or 6 (Ran shRNA +Vector, Ran shRNA +Ran-GTP)
spots analyzed over two replicates per group.
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CHAPTER 4
Discussion: molecular complexity and versatility are emerging
themes in axon biology
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Conclusion
The field of axon biology is incredibly complex, encompassing elements of epigenetics,
cytoskeletal biology, molecular motor biology, bioenergetics, translational regulation, membrane
biology, and many other fields. Whittling the field down to axon growth does not change the
scale of complexity, as most elements that are necessary for axon homeostasis are also necessary
for axon growth during development or regeneration. Therefore any examination of axon biology
will be underrepresentative of the field, but careful study of components of this delicate system
can lead to insights into how the axon functions generally. The work presented here supports two
increasingly clear phenomena of axon biology. First, regulatory systems in the axon are multilayered, which enables fine-tuning of diverse systems, including the axon transport system.
Second, proteins in the axon are versatile, serving distinct functions based on their localization or
the temporal needs of the neuron.

Regulating the molecular motor regulators
The regulation of axonal transport remains a primary concern for neurobiology. Neurons
are postmitotic and therefore uniquely susceptible to aberrations in their cell biology.
Furthermore, neurons are the largest cells in the body and therefore rely heavily on directed
transport to survive and respond to their environments. Therefore understanding how axonal
transport is regulated is key to understanding axonal biology.
The work presented here in Chapter 2 contributed importantly to the field of neuronal
transport regulation, demonstrating that JIP3 was capable of independently activating tetrameric
kinesin-1 for motility, and that differential binding to the KLC and KHC subunits has distinct
effects on kinesin-1 function. Interestingly, JIP3 also binds dynein and regulates retrograde

126

signaling (1). Indeed, JIP3 seems to be a bidirectional motor regulator depending on its cargo
and motor binding partners (2). How does JIP3 regulate the transport of multiple cargoes and
multiple motors? Interesting insights into this question have recently come from the Holzbaur
group as they study JIP1, a protein that is structurally and functionally related to JIP3. JIP1 also
regulates kinesin-1 motility via direct binding to its KHC subunits (3). Interestingly, JIP1 also
functions as a switch, enabling long-range retrograde transport of autophagosomes (4). JIP1
therefore both relives autoinhibition of KHC to promote anterograde transport and enhances
KHC autoinhibition to promote retrograde transport. JIP1 achieves these opposing functions by
binding other cargo adaptors, specifically LC3, and via phosphorylation-dependent activity
regulation. Preliminary data in our lab has identified multiple sites of in vivo phosphorylation on
JIP3, at least one of which promotes axon elongation (preliminary data not shown). It will be
interesting to see how activity of JIP3 and other cargo adaptor proteins is precisely tuned to
support multiple modes of transport.

Novel functions for nuclear proteins
A fundamental question in the axon biology field is how the axon and cell body
coordinate their activities to support axon growth, homeostasis and injury response. As focus in
the field has shifted towards epigenetic regulation of neural growth state, a growing contingent
of proteins is being recognized as having distinct function in the axon versus the cell body, and
especially the nucleus. It seems the remote location of the axon has enabled repurposing of
nuclear proteins for novel purposes in the axon. Localization-dependent protein versatility
maximizes efficiency in the neuron, especially enabling efficient signaling between the cell body
and axon.
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Epigenetic modulators are interesting candidates for coupling nuclear activity to axonal
biology, since they are partially responsible for the large-scale transcriptional changes that often
accompany axon outgrowth during development or injury. The growing tip of an axon is usually
far removed from the nucleus, and the growth cone is a temporary structure, the presence of
which typically coincides with large-scale transcriptional changes, i.e. during neuronal
development or after axonal injury. Additionally, temporary large-scale cytoskeletal
reorganization is a hallmark of both nuclear and axonal biology during mitosis and outgrowth,
respectively. Therefore it would be efficient for the neuron to couple epigenetic regulation to
microtubule remodeling. The case of HDAC5 during axon regeneration is an example of this
phenomenon (5–7). HDAC5 was originally studied as an epigenetic modulator of chromatin
compaction via its histone deacetylase function before being appreciated as a microtubule
deacetylase. After injury, a fast calcium wave induces HDAC5 export from the nucleus, causing
injury-associated epigenetic changes to promote axon regeneration somatically. HDAC5 is then
transported to the axon, where it functions as a tubulin deacetylase, promoting microtubule
instability and axon regeneration axonally. The redistribution of HDAC5 happens in multiple
phases, yoking the short-term injury response of cytoskeletal reorganization in the axon to more
long-term transcriptomic injury responses. Further, the model of post-injury HDAC5
redistribution could theoretically be generalized to other nuclear proteins (Figure 1). This model
efficiently couples nuclear transcription programs to axonal regeneration, as redistributed nuclear
proteins would exert cellular effects more quickly than changes in transcriptional programs. A
biphasic response to modify or generate growth cones results: an initial, fast response as nuclear
proteins are redistributed from nucleus to axon tip, causing chromatin remodeling and beginning
axonal tubulin reorganization; and a slower response wherein newly activated growth cone-
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modulating genes are transcribed, translated and trafficked to the growing axon tip. This
coupling mechanism could be used in either growth or development. Importantly, this establishes
a paradigm whereby axon-specific functions of primarily nuclear proteins are a feature of
neuronal signaling.
Since Ran has known functions as both a nucleocytoplasmic trafficking protein and as a
microtubule organizing protein, it is a prime candidate for coupling somatic and axonal biology
(Figure 2). The Fainzilber group has developed a model wherein the nucleotide binding state of
Ran functions as a switch for retrograde transport of injury signaling. In adult axons, Ran-GTP is
highly enriched and binds an importin/dynein complex, preventing its binding to nuclear
localization signal (NLS)-containing cargoes. After injury, newly-transcribed RanGAP rapidly
hydrolyzes Ran-GTP to Ran-GDP, allowing the importin/dynein complex to bind NLS cargoes,
which are transported back to the cell body as positive injury signals (8). The data presented in
Chapter 3 build on this model by defining the role of Ran in axon development as opposed to
injury. Interestingly, these data are also consistent with a Ran nucleotide binding state-dependent
switch on retrograde transport. There are two main differences between the Fainzilber model of
Ran function in axon injury signaling and the model presented here for Ran function in axon
growth: the direction of the Ran nucleotide binding switch, and the identity of the retrograde
cargo. The Fainzilber model proposes enrichment Ran-GDP at injured axon tips, while we
propose enrichment of Ran-GTP at growing axon tips. The enrichment of Ran-GDP is generated
by newly transcribed Ran GAP in the Fainzilber model, while active Ran-GTP in our model is
generated by the enrichment of the Ran GEF RBP10 at growing axon tips. The enrichment of
Ran-GTP at growing axon tips during development could theoretically serve two purposes:
growth cone-enriched Ran-GTP might modulate microtubule dynamics via effector proteins, or

129

conversion of Ran-GDP to –GTP might aid in maturation of the axon (after all, Ran-GTP is the
predominant binding state in adult axons, per Fainzilber). Both of these functions are supported
by the data presented here: Ran knockdown both reduces growth cone microtubule dynamics as
measured by SiR-tubulin and causes ectopic enrichment of RBP10 in growth cones. This second
piece of evidence suggests that RanBP10 is a Ran-dependent retrograde axonal cargo, as
opposed to the importin cargo proposed in injury signaling. Why is RBP10 a retrograde cargo? It
is interesting to ruminate on this question in the context of another model proposed by the
Fainzilber group, the oscillating signal model for axon length sensing (9), since RBP10 could
theoretically function as a self-regulating oscillating signal. That is, RBP10 can promote its own
retrograde transport by converting Ran-GDP to –GTP, since Ran GEFs preferentially bind RanGDP. An oscillating RBP10 retrograde injury signal could be achieved in one of two ways. First,
RBP10 mRNA might be transported to the axon in timed waves and subsequently translated
there. Alternatively, RBP10 protein at the axon tip could generate its own oscillating signal via
Ran-GTP: as RBP10 is retrogradely transported to the cell body, production of Ran-GTP in the
axon tip would diminish, creating local enrichment of Ran-GDP, which would bind RBP10 ad
inhibit its retrograde transport to the soma, which would cause increased accumulation of RBP10
at the axon tips, which would increase production of Ran-GTP at the axon tip, which would
increase retrograde transport of RBP10 to the cell body, and so on. If Ran indeed functions as a
retrograde signaling sequester protein during development as it does during injury, the exact
function of this retrograde cargo is indeed worthy of further exploration.

130

Figure 1: Proposed mechanism of coupling epigenetic regulation to axonal signaling via
dynamic relocalization of dual-purpose proteins. (A) Summary of recent work out of the
Cavalli lab establishing the dynamic relocalization of HDAC5 in response to injury signaling.
Suppression of HDAC5’s canonical function in the nucleus is achieved when the protein is
exported from the nucleus and anterogradely transported to the distal axon tip. This has dual
effects, activating a pro-regenerative transcriptional program in the soma and remodeling
microtubules in the distal axons. (B) A generalized model coupling epigenetic regulation to
axonal biology. Dynamic relocalization of chromatin modeling proteins creates a biphasic
response: relocalization of nuclear proteins to the axon could enable short-term effects via
noncanonical functions (for example, regulating microtubule dynamics) while simultaneously
triggering long-term changes in transcriptional programs.
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Figure 2: Proposed role for Ran regulating axonal retrograde signaling during injury and
development. (A) Summary of recent work from the Fainzilber group establishing Ran as a
retrograde injury signaling regulator. (1) After injury, newly transcribed RanGAP converts RanGTP to Ran-GDP. (2) A dynein-coupled complex is released via release of importin, which
preferentially binds Ran-GTP. (3) Retrograde transport of the importin-dynein injury signal
enables pro-regenerative transcriptional reprogramming. (B) Proposed role for Ran-GTPase in
axon development. (1) RBP10, either transcribed in the growth cone de novo or transported to
the growing axon tip, converts Ran-GDP to Ran-GTP. (2) Growth cone-enriched Ran-GTP
promotes microtubule remodeling via effector proteins. (3) Oscillating retrograde transport of
RBP10 informs somatic sensors of axon length.
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